Professor John E Brazier

BA (Exeter), MSc (York), PhD (Sheffield)

School of Medicine and Population Health

Emeritus Professor

Professor John Brazier
Profile picture of Professor John Brazier
j.e.brazier@sheffield.ac.uk

Full contact details

Professor John E Brazier
School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
Profile

I am Emeritus Professor in the School of Health and Related Research (ScHARR) at the University of Sheffield. I have been a health economist for 40 years. My special interest is in the measurement and valuation of health for economic evaluation where I have published widely.

I am perhaps best known for my work in developing a preference-based measure of health for the SF-36 (SF-6D), but with colleagues have further developed and extended these methods to a number of specific conditions including measures in asthma, cancer, overactive bladder, diabetes, mental health, dementia and epilepsy. Most recently with colleagues across six countries developed a new generic measure of health and wellbeing called the EQ-HWB for health and social care users and their informal carers.

My methods research has also examined issues around reviewing utility measures, mapping between measures, valuation methods (including the use of DCE), using utilities in cost effectiveness models and developing ways to incorporate equity concerns such as burden of disease into the weights applied to QALYs and the role of well-being in economic evaluation. I have been a member of the National Institute for Clinical Excellence (NICE) Technology Appraisal Committee and has been an adviser on various aspects benefit measurement to NICE.

Publications

Show: Featured publications All publications

Books

  • Brazier J, Ratcliffe J, Saloman J & Tsuchiya A (2016) Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press.

Journal articles

  • Brazier JE, Rowen DL, Lloyd A & Karimi M (2019) . Value in Health, 22(1), 62-68.
  • Rowen DL, Labeit A, Stevens K, Elliot J, Mulhern B, Carlton J, Basarir H & Brazier J (2018) . Medical Decision Making, 38(6), 699-707.
  • Keetharuth D, Brazier J, Connell J, Bjorner J, Carlton J, Taylor Buck E, Ricketts T, McKendrick K, Browne J, Croudace T & Barkham M (2018) . The British journal of psychiatry : the journal of mental science, 212(1), 42-49.
  • Finch AP, Brazier JE, Mukuria C & Bjorner JB (2017) . Value in Health.
  • Stevens K, Brazier J & Rowen DL (2017) . European Journal of Health Economics.
  • Rowen D, Brazier J, Mukuria C, Keetharuth A, Risa Hole A, Tsuchiya A, Whyte S & Shackley P (2016) . Medical Decision Making, 36(2), 210-222.
  • Brazier J & Tsuchiya A (2015) . Applied Health Economics and Health Policy, 13(6), 557-565.
  • Connell J, O'Cathain A & Brazier J (2014) . Social Science & Medicine, 120, 12-20.
  • Mukuria C, Brazier J, Barkham M, Connell J, Hardy G, Hutten R, Saxon D, Dent-Brown K & Parry G (2013) . Br J Psychiatry, 202(3), 220-227.
  • Brazier JE & Roberts J (2004) . Med Care, 42(9), 851-859.
  • Brazier J, Roberts J & Deverill M (2002) . J Health Econ, 21(2), 271-292.
  • Akehurst R, Anderson P, Brazier JE, Brennan A, Briggs , Buxton M & et al (2000) Decision analytic modelling in the economics evaluation of health care technologies: a consensus statement. PharmacoEconomics(4), 161-163.
  • Brazier JE (2000) Decision Analytic modelling in the Economic Evaluation of Health Technologies: A consensus statement. PharmacoEconomics, 5(17), 443-444.

All publications

Books

  • Brazier J, Ratcliffe J, Saloman J & Tsuchiya A (2016) Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press.
  • Brazier JE, Ratcliffe J, Tsuchiya A & Salomon J (2007) Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press.
  • Brazier JE, Stevens A, Abrams K, Fitzpatrick R & Lilford R (2001) Methods in Health Technology Assessment. London: Sage Books.
  • Brazier JE, Black N, Fitzpatrick R & Reeves B (1999) Methods for Health Services Research: a state of the art guide.. London: BMJ Books.

Journal articles

  • Acaster S, Mukuria C, Rowen D, Brazier J, Wainwright C, Quon B, Duckers J, Quittner A, Lou Y, Sosnay P & McGarry L (2022) Development of the CFQ-R-8D: estimating utilities from the cystic fibrosis questionnaire-revised. Value in Health.
  • Powell PA, Karimi M, Rowen D, Devlin N, van Hout B & Brazier JE (2022) . Quality of Life Research.
  • Broderick L, Bjorner JB, Lauher-Charest M, White MK, Kosinski M, Mulhern B & Brazier J (2022) . Value in Health.
  • Broderick L, Bjorner JB, Lauher-Charest M, White MK, Kosinski M, Mulhern B & Brazier J (2022) . Journal of Patient-Reported Outcomes, 6(1).
  • Brazier J, Peasgood T, Mukuria C, Marten O, Kreimeier S, Luo N, Mulhern B, Pickard AS, Augustovski F, Greiner W , Engel L et al (2022) . Value in Health.
  • Carlton J, Peasgood T, Mukuria C, Connell J, Brazier J, Ludwig K, Marten O, Kreimeier S, Engel L, Belizán M , Yang Z et al (2022) . Value in Health.
  • Schneider P, van Hout B, Heisen M, Brazier J & Devlin N (2022) . Wellcome Open Research, 7.
  • Peasgood T, Mukuria C, Brazier J, Marten O, Kreimeier S, Luo N, Mulhern B, Greiner W, Pickard AS, Augustovski F , Engel L et al (2022) . Value in Health.
  • Mukuria C, Connell J, Carlton J, Peasgood T, Scope A, Clowes M, Rand S, Jones K & Brazier J (2022) . Value in Health.
  • Mulhern B, Norman R & Brazier J (2021) . PharmacoEconomics, 39(10), 1151-1162.
  • Shah KK, Bennett B, Lenny A, Longworth L, Brazier JE, Oppe M, Pickard AS & Shaw JW (2021) . The European Journal of Health Economics.
  • Broderick L, Bjorner J, Lauher M, Kosinski M, White MK, Mulhern B & Brazier JE (2021) . Value in Health, 24, S193-S193.
  • McDool E, Mukuria C & Brazier J (2021) . PharmacoEconomics.
  • King MT, Norman R, Mercieca-Bebber R, Costa DSJ, McTaggart-Cowan H, Peacock S, Janda M, Müller F, Viney R, Pickard AS , Cella D et al (2021) . Value in Health.
  • Pennington R, Alshreef A, Flight L, Metry A, Poku E, Hykin P, Sivaprasad S, Prevost AT, Vasconcelos JC, Murphy C , Kelly J et al (2021) . PharmacoEconomics.
  • Zoratti MJ, Pickard AS, Stalmeier PFM, Ollendorf D, Lloyd A, Chan KKW, Husereau D, Brazier JE, Krahn M, Levine M , Thabane L et al (2021) . Eur J Health Econ.
  • Terheyden JH, Behning C, Lüning A, Wintergerst L, Basile PG, Tavares D, Melício BA, Leal S, Weissgerber G, Luhmann UFO , Crabb DP et al (2021) . BMC Medical Research Methodology, 21.
  • Wu J, Xie S, He X, Chen G, Bai G, Feng D, Hu M, Jiang J, Wang X, Wu H , Wu Q et al (2021) . PharmacoEconomics.
  • Keetharuth D, Rowen D, Bjorner J & Brazier J (2021) . Value in Health, 24(2), 281-290.
  • Finch AP, Brazier J & Mukuria C (2021) . Medical Decision Making, 41(1), 89-99.
  • Scarisbrick J, Schmidt F, Turini MM, D'agostino P, Thornton S, Evans J, Ader J, van Hest N & Brazier JE (2020) . Value in Health, 23, S715-S715.
  • Shah K, Bennett B, Lenny A, Longworth L, Brazier JE, Oppe M, Pickard AS & Shaw JW (2020) . Value in Health, 23, S430-S430.
  • Di Tanna GL, Urbich M, Wirtz HS, Potrata B, Heisen M, Bennison C, Brazier J & Globe G (2020) . PharmacoEconomics.
  • Xie S, Wu J, He X, Chen G & Brazier JE (2020) . Value in Health, 23(10), 1391-1399.
  • Terheyden JH, Holz FG, Schmitz-Valckenberg S, Lüning A, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A , Sánchez CI et al (2020) . Trials, 21(1).
  • Peasgood T, Bhardwaj A, Brazier JE, Biggs K, Coghill D, Daley D, Cooper CL, De Silva C, Harpin V, Hodgkins P , Nadkarni A et al (2020) . Journal of Attention Disorders.
  • Pennington BM, Hernández-Alava M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J (2020) . Value in Health.
  • Brazier J, Mulhern B, Bjorner JB, Gandek B, Rowen D, Alonso J, Vilagut G & Ware J (2020) . Medical Care, 58(6), 557-565.
  • Mulhern BJ, Bansback N, Norman R & Brazier J (2020) . Medical Care.
  • Ara R, Hill H, Lloyd A, Woods HB & Brazier J (2020) . Value in Health, 23(3), 397-405.
  • Kharroubi SA, Beyh YS, Brazier J & Yang Y (2020) . Quality of Life Research.
  • Kharroubi S, Beyh Y, El Harake M, Dawoud D, Rowen D & Brazier J (2020) . International Journal of Environmental Research and Public Health, 17(3).
  • Wu J, Xie S, He X, Chen G & Brazier JE (2020) . Quality of Life Research.
  • Norman R, Mercieca-Bebber R, Rowen D, Brazier J, Cella D, Pickard AS, Street DJ, Viney R, Revicki D & King M (2019) . Health Economics, 28(12), 1385-1401.
  • Meier P, Purshouse R, Bain M, Bambra C, Bentall R, Birkin M, Brazier J, Brennan A, Bryan M, Cox J , Fell G et al (2019) . Wellcome Open Research, 4.
  • Karimi M, Brazier J & Paisley S (2019) . Value in Health.
  • Poder TG, Fauteux V, He J & Brazier JE (2019) . Value in Health, 22(7), 837-842.
  • Matza LS, Brazier JE, Stewart KD, Pinto L, Bender RH, Kircik L, Jordan J, Kim KJ, Mutebi A, Viswanathan HN & Menter A (2019) . Journal of Medical Economics.
  • Mukuria C, Rowen D, Harnan S, Rawdin A, Wong R, Ara R & Brazier J (2019) . Applied Health Economics and Health Policy, 17(3), 295-313.
  • Wu J, Xie S, He X, Chen G & Brazier JE (2019) . Value in Health, 22, S327-S328.
  • Xie S, He X, Wu J, Chen G & Brazier JE (2019) . Value in Health, 22, S326-S327.
  • Grundy A, Keetharuth D, Barber R, Carlton J, Connell J, Taylor Buck E, Barkham M, Ricketts T, Robotham D, Rose D , Kay J et al (2019) . Health and Quality of Life Outcomes, 17.
  • Powell PA, Carlton J, Rowen D & Brazier J (2019) . BMJ Open, 9.
  • Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-Séverac H, Crawford B, Cruz L, Karnon J, Lloyd A, Paisley S & Pickard AS (2019) . Value in Health, 22(3), 267-275.
  • Franklin M, Mukuria C, Mulhern B, Tran I, Brazier J & Watson S (2019) . The Patient - Patient-Centered Outcomes Research, 1-13.
  • Caro JJ, Brazier JE, Karnon J, Kolominsky-Rabas P, McGuire AJ, Nord E & Schlander M (2019) . PharmacoEconomics, 37(3), 293-299.
  • Peasgood T, Carlton J & Brazier J (2019) . Economies, 7(1).
  • Terheyden JH, Finger RP, Schmitz-Valckenberg S, Agostini H, Dahlke C, Kuehlewein L, Lang GE, Pauleikhoff D, Wolf A, Boettger MK , Luhmann UFO et al (2019) . Der Ophthalmologe, 116(12), 1186-1193.
  • Brazier JE, Rowen DL, Lloyd A & Karimi M (2019) . Value in Health, 22(1), 62-68.
  • Finger RP, Schmitz-Valckenberg S, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Sánchez CI, Margaron P , Normand G et al (2019) . Ophthalmologica, 241(2), 61-72.
  • Keetharuth D, Bjorner JB, Barkham M, Browne J, Croudace T & Brazier J (2018) . Quality of Life Research.
  • Uttley L, Carlton J, Woods HB & Brazier J (2018) . Health and Quality of Life Outcomes, 16.
  • Ballinger R, Macey J, Lloyd A, Brazier J, Ablett J, Burden S & Lal S (2018) . Clinical Therapeutics, 40(11), 1878-1893.e1.
  • Patel PJ, Steel DH, Hirneiß C, Brazier J, Aly A & Lescrauwaet B (2018) . Eye (Basingstoke).
  • Priedane E, Phillips GA, Brazier JE, Johnson C, Gomes-Faria R & Kumar A (2018) . Value in Health, 21, S469-S470.
  • Foster A, Croot L, Brazier J, Harris J & O'Cathain A (2018) . Journal of Patient-Reported Outcomes.
  • Finch AP, Brazier JE & Mukuria C (2018) . Value in Health.
  • Whalley D, Globe G, Crawford R, Doward L, Tafesse E, Brazier J & Price D (2018) . Health and Quality of Life Outcomes, 16.
  • Rowen DL, Labeit A, Stevens K, Elliot J, Mulhern B, Carlton J, Basarir H & Brazier J (2018) . Medical Decision Making, 38(6), 699-707.
  • Keetharuth D, Taylor Buck E, Acquadro C, Conway K, Connell J, Barkham M, Carlton J, Ricketts TN, Barber R & Brazier JE (2018) . International Journal of Environmental Research and Public Health, 15(7), 1342-1342.
  • Devlin N, Brazier J, Pickard AS & Stolk E (2018) . PharmacoEconomics, 36, 637-640.
  • Devlin N, Brazier J, Simon Pickard A & Stolk E (2018) . PharmacoEconomics, 36(6), 729-729.
  • Keetharuth D, Brazier J, Connell J, Bjorner J, Carlton J, Taylor Buck E, Ricketts T, McKendrick K, Browne J, Croudace T & Barkham M (2018) . The British journal of psychiatry : the journal of mental science, 212(1), 42-49.
  • Brazier J, Briggs A & Bryan S (2018) . Health Economics, 27(1), 4-6.
  • Rowen DL, Stevens K, Labeit A, Elliott J, Mulhern B, Carlton J, Basarir H, Ratcliffe J & Brazier J (2018) . Value in Health, 21(1), 69-77.
  • King MT, Viney R, Pickard AS, Rowen DL, Aaronson NK, Brazier JE, Cella DF, Costa DSJ, Fayers PM, Kemmler G , McTaggart-Cowan H et al (2017) . Phamacoeconomics.
  • Ara R & Brazier J (2017) . PharmacoEconomics.
  • Ara RM, Peasgood T, Mukuria C, Chevrou-Severac H, Rowen D, Azzabi-Zouraq I, Paisley S, van Hout B & Brazier J (2017) . PharmacoEconomics, 35(Suppl 1), 7-9.
  • Ara R, Brazier J & Young T (2017) . PharmacoEconomics.
  • Ara RM, brazier J & azzabi-zouraq I (2017) . PharmacoEconomics, 35(Suppl 1), 77-88.
  • Ara R, Brazier J, Peasgood T & Paisley S (2017) . PharmacoEconomics, 35(Suppl 1), 43-55.
  • Brazier J, Ara R, Rowen DL & Chevrou-Severac H (2017) . PharmacoEconomics, 35(Suppl 1), 21-31.
  • Rowen DL, Brazier J, Ara R & Azzabi Zouraq I (2017) . PharmacoEconomics, 35(Suppl 1), 33-41.
  • Tong T, Thokala P, McMillan B, Ghosh R & Brazier J (2017) . International Journal of Geriatric Psychiatry, 32(12), 1392-1400.
  • Brazier J, Rowen DL, Karimi M, Peasgood T, Tsuchiya A & Ratcliffe J (2017) . The European Journal of Health Economics.
  • Brazier JE, Muston D, Konwea H, Power GS, Barzey V, Lloyd A, Sowade O, Vitti B, Gerlinger C & Roberts J (2017) . Investigative Ophthalmology and Visual Science, 58(11), 4818-4825.
  • Mulhern B, Labeit A, Rowen DL, Knowles E, Meadows K, Elliott J & Brazier J (2017) . Diabetic Medicine, 34(9), 1264-1275.
  • Carlton J, Elliott J, Rowen D, Stevens K, Basarir H, Meadows K & Brazier J (2017) . Health and Quality of Life Outcomes, 15.
  • Finch AP, Brazier JE, Mukuria C & Bjorner JB (2017) . Value in Health.
  • Stevens K, Brazier J & Rowen DL (2017) . European Journal of Health Economics.
  • Finch AP, Brazier JE & Mukuria C (2017) . European Journal of Health Economics, 19(4), 557-570.
  • Karimi M, Brazier J & Paisley S (2017) . Health and Quality of Life Outcomes, 15.
  • Mulhern B, Pink J, Rowen D, Borghs S, Butt T, Hughes D, Marson A & Brazier J (2017) . Value in Health, 20(4), 687-693.
  • Saxon D, Ashley K, Bishop-Edwards L, Connell J, Harrison P, Ohlsen S, Hardy GE, Kellett S, Mukuria C, Mank T , Bower P et al (2017) . Trials, 18(1), 93-93.
  • Mukuria C, Young T, Keetharuth A, Borghs S & Brazier J (2017) . Quality of Life Research, 26(3), 749-759.
  • Kearns B, Rafia R, Leaviss J, Preston L, Brazier JE, Palmer S & Ara R (2017) . BMC Health Services Research, 17(1), 78-78.
  • Mulhern B, Norman R, Lorgelly P, Lancsar E, Ratcliffe J, Brazier J & Viney R (2017) . PharmacoEconomics, 35(4), 439-451.
  • Karimi M, Brazier J & Paisley S (2016) . Social Science & Medicine, 172, 80-88.
  • Lorgelly PK, Doble B, Rowen D, Brazier J & Cancer 2015 investigators (2016) . Qual Life Res.
  • Peasgood T, Bhardwaj A, Biggs K, Brazier JE, Coghill D, Cooper CL, Daley D, De Silva C, Harpin V, Hodgkins P , Nadkarni A et al (2016) . European Child & Adolescent Psychiatry, 25(11), 1217-1231.
  • Hall JP, Gurung SP, Keane PM, Poynton FE, Cardin DJ, Sorensen T, Winter G, Gunnlaugsson T, Sazanovich IV, Towrie M , Kelly JM et al (2016) . Acta Crystallographica Section A Foundations and Advances, 72(a1), s49-s50.
  • Ratcliffe J, Huynh E, Chen G, Stevens K, Swait J, Brazier J, Sawyer M, Roberts R & Flynn T (2016) . Social Science & Medicine, 157, 48-59.
  • Feher MD, Brazier J, Schaper N, Vega-Hernandez G, Nikolajsen A & Bøgelund M (2016) . BMJ Open Diabetes Research and Care, 4(1).
  • Keane PM, Baptista FR, Gurung SP, Devereux SJ, Sazanovich IV, Towrie M, Brazier JA, Cardin CJ, Kelly JM & Quinn SJ (2016) . ChemPhysChem, 17(9), 1388-1388.
  • King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R , Pickard AS et al (2016) . Quality of Life Research, 25(3), 625-636.
  • Karimi M & Brazier J (2016) . PharmacoEconomics, 34(7), 645-649.
  • Keane PM, Baptista FR, Gurung SP, Devereux SJ, Sazanovich IV, Towrie M, Brazier JA, Cardin CJ, Kelly JM & Quinn SJ (2016) . ChemPhysChem, 17(9), 1281-1287.
  • Rowen D, Brazier J, Mukuria C, Keetharuth A, Risa Hole A, Tsuchiya A, Whyte S & Shackley P (2016) . Medical Decision Making, 36(2), 210-222.
  • Rowen D, Brazier J, Keetharuth A, Tsuchiya A & Mukuria C (2016) . Applied Health Economics and Health Policy, 14(1), 89-104.
  • Croudace T, Brazier J, Gutacker N, Street A, Robotham D, Waterman S, Rose D, Satkunanathan S, Wykes T, Nasr N , Enderby P et al (2016) Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Sheffield 2016: advances in patient reported outcomes research : Sheffield, UK. 9th June 2016. Health and quality of life outcomes, 14(Suppl 1).
  • Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS , Rowen D et al (2016) . Quality of Life Research, 25(3), 637-649.
  • Tilling C, Krol M, Attema AE, Tsuchiya A, Brazier J, van Exel J & Brouwer W (2016) . The European Journal of Health Economics, 17(7), 801-809.
  • Ratcliffe J, Huynh E, Stevens K, Brazier J, Sawyer M & Flynn T (2016) . Health Economics (United Kingdom), 25(4), 486-496.
  • Ferreira LN, Ferreira PL, Pereira LN, Brazier J & Rowen D (2015) A Portuguese Value Set for the SF-6D (vol 13, pg 624, 2010). VALUE IN HEALTH, 18(8), 1162-1162.
  • Ferreira LN, Ferreira PL, Pereira LN, Rowen D & Brazier JE (2015) Exploring the Consistency of the SF-6D (vol 16, pg 1023, 2013). VALUE IN HEALTH, 18(8), 1162-1162.
  • Yang Y, Brazier J & Longworth L (2015) . The European Journal of Health Economics, 16(9), 927-939.
  • Mulhern B, O’Gorman H, Rotherham N & Brazier J (2015) . Health and Quality of Life Outcomes, 13(1).
  • Mulatero C, Lal R, Jewitt K, Tolley C, Wells J, Arbuckle R, Lloyd A, Brazier J & Devlin N (2015) . Value in Health, 18(7), A469-A469.
  • Peasgood T & Brazier J (2015) . PharmacoEconomics, 33(11), 1101-1105.
  • Hall JP, Poynton FE, Keane PM, Gurung SP, Brazier JA, Cardin DJ, Winter G, Gunnlaugsson T, Sazanovich IV, Towrie M , Cardin CJ et al (2015) . Nature Chemistry, 7(12), 961-967.
  • Bansback N, Mulhern B, Sawatzky R, Brazier J & Whitehurst DG (2015) Valuing the SF-6D Version 2 in Canada. QUALITY OF LIFE RESEARCH, 24, 180-181.
  • Young TA, Mukuria C, Rowen D, Brazier JE & Longworth L (2015) . Medical Decision Making, 35(7), 912-926.
  • Brazier J & Tsuchiya A (2015) . Applied Health Economics and Health Policy, 13(6), 557-565.
  • Mukuria C, Rowen D, Brazier JE, Young TA & Nafees B (2015) . Value in Health, 18(6), 846-855.
  • Hall JP, Poynton FE, Keane PM, Gurung SP, Brazier JA, Cardin DJ, Winter G, Gunnlaugsson T, Sazanovich IV, Towrie M , Cardin CJ et al (2015) . Acta Crystallographica Section A Foundations and Advances, 71(a1), s492-s493.
  • Kikuta K, Piao H, Brazier J, Taniguchi Y, Onizuka K, Nagatsugi F & Sasaki S (2015) . Bioorg Med Chem Lett, 25(16), 3307-3310.
  • Ratcliffe J, Chen G, Stevens K, Bradley S, Couzner L, Brazier J, Sawyer M, Roberts R, Huynh E & Flynn T (2015) . Applied Health Economics and Health Policy, 13(5), 485-492.
  • Mulhern B, Brazier J & Bjorner JB (2015) . Value in Health, 18(3), A27-A27.
  • Rowen D, Brazier J & Van Hout B (2015) . Medical Decision Making, 35(3), 328-340.
  • Marques da Silva P, Haag U, Guest JF, Brazier JE & Soro M (2015) . Health and Quality of Life Outcomes, 13(1), 24-24.
  • Kerr C, Breheny K, Lloyd A, Brazier J, Bailey DB, Berry-Kravis E, Cohen J & Petrillo J (2015) . Quality of Life Research, 24(2), 305-314.
  • Chen G, Flynn T, Stevens K, Brazier J, Huynh E, Sawyer M, Roberts R & Ratcliffe J (2015) . Value in Health, 18(4), 432-438.
  • Yang Y, Rowen D, Brazier J, Tsuchiya A, Young T & Longworth L (2015) . Value in Health, 18(1), 52-60.
  • Rowen D, Mulhern B, Banerjee S, Tait R, Watchurst C, Smith SC, Young TA, Knapp M & Brazier JE (2015) . Medical Decision Making, 35(1), 68-80.
  • Wu M, Brazier JE, Kearns B, Relton C, Smith C & Cooper CL (2015) . European Journal of Health Economics, 16(2), 141-151.
  • Hall JP, Sanchez-Weatherby J, Alberti C, Quimper CH, O’Sullivan K, Brazier JA, Winter G, Sorensen T, Kelly JM, Cardin DJ & Cardin CJ (2014) . Journal of the American Chemical Society, 136(50), 17505-17512.
  • Longworth L, Singh J & Brazier J (2014) . Value in Health, 17(7), A570-A570.
  • O'Gorman H, Mulhern B, Brazier J & Rotherham N (2014) . Value in Health, 17(7), A517-A517.
  • Nafees B, Cowie MR, Patel C, Deschaseaux C, Brazier J & Lloyd AJ (2014) . Value in Health, 17(7), A493-A493.
  • Connell J, O'Cathain A & Brazier J (2014) . Social Science & Medicine, 120, 12-20.
  • Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella D, Grimison P, Janda M, McTaggart-Cowan H, Pickard AS & Arbuckle R (2014) The development of cancer-specific multi-attribute utility instruments from the EORTC QLQ-C30 and FACT-G. QUALITY OF LIFE RESEARCH, 23, 28-29.
  • Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D & Brazier J (2014) . Br J Psychiatry, 205(3), 236-243.
  • Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, Ratcliffe J & Street D (2014) . Med Decis Making, 34(6), 773-786.
  • Ara R, Kearns B, vanHout BA & Brazier JE (2014) . BMC Research Notes, 7(1).
  • Kharroubi SA, Brazier JE & Yang Y (2014) . Value Health, 17(4), 406-415.
  • Mulhern B, Rowen D, Snape D, Jacoby A, Marson T, Hughes D, Baker G & Brazier J (2014) . Epilepsy Behav, 36, 12-17.
  • Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, Lloyd MJ, Paisley S, O’Cathain A, Barkham M , Knapp M et al (2014) . Health Technology Assessment, 18(34).
  • Wu M, Brazier J, Relton C, Cooper C, Smith C & Blackburn J (2014) . Health and Quality of Life Outcomes, 12(1).
  • Rentz AM, Kowalski JW, Walt JG, Hays RD, Brazier JE, Yu R, Lee P, Bressler N & Revicki DA (2014) . JAMA Ophthalmol, 132(3), 310-318.
  • Whitehurst DGT, Norman R, Viney R & Brazier JE (2014) . Value in Health.
  • Kharroubi SA, Brazier JE & McGhee S (2014) . Value in Health.
  • Yang Y, Brazier J & Tsuchiya A (2014) . Medical Decision Making, 34(1), 42-53.
  • Matza LS, Currie B, Palsgrove A, Davies E, Chung K, Braun A, Van Brunt K, Brazier JE & Body J-J (2014) . European Journal of Health Economics, 15(1), 7-18.
  • Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P , Devianee Keetharuth A et al (2014) . Health Technol Assess, 18(9), 1-224.
  • Mulhern B, Bansback N, Brazier J, Buckingham K, Cairns J, Devlin N, Dolan P, Hole AR, Kavetsos G, Longworth L , Rowen D et al (2014) . Health Technol Assess, 18(12), vii-191.
  • Poku E, Brazier J, Carlton J & Ferreira A (2013) . BMC Ophthalmol, 13, 74.
  • Yang Y, Longworth L & Brazier J (2013) . Quality of Life Research, 1-16.
  • Sprange K, Mountain GA, Brazier J, Cook SP, Craig C, Hind D, Walters SJ, Windle G, Woods R, Keetharuth AD , Chater T et al (2013) . Trials, 14, 302.
  • Ferreira LN, Ferreira PL, Pereira LN, Rowen D & Brazier JE (2013) . Value Health, 16(6), 1023-1031.
  • Kharroubi SA, Brazier JE & McGhee S (2013) . Value in Health, 16(6), 1032-1045.
  • Al-Janabi H, Coast J, Peters TJ, Brazier J, Bryan S, Flynn TN, Clemens S & Moody A (2013) . Quality of Life Research, 22(7), 1831-1840.
  • Craig BM, Pickard AS, Stolk E & Brazier JE (2013) . Medical Decision Making, 33(6), 793-803.
  • Papaioannou D, Brazier J & Paisley S (2013) . Value in Health, 16(4), 686-695.
  • Alava MH, Brazier J, Rowen D & Tsuchiya A (2013) . Med Decis Making, 33(6), 839-852.
  • Bansback N, Brazier J, Tsuchiya A & Anis A (2013) . Journal of Health Economics, 32(2), 486-486.
  • Papaioannou D, Brazier J & Parry G (2013) . J Pers Disord, 27(3), 383-401.
  • Mulhern B, Rowen D, Brazier J, Smith S, Romeo R, Tait R, Watchurst C, Chua K-C, Loftus V, Young T , Lamping D et al (2013) . Health Technol Assess, 17(5), v-140.
  • Mukuria C, Brazier J, Barkham M, Connell J, Hardy G, Hutten R, Saxon D, Dent-Brown K & Parry G (2013) . Br J Psychiatry, 202(3), 220-227.
  • Alonso J, Bartlett SJ, Rose M, Aaronson NK, Chaplin JE, Efficace F, Leplège A, LU A, Tulsky DS, Raat H , Ravens-Sieberer U et al (2013) . Health and Quality of Life Outcomes, 11(1), 210-210.
  • Lloyd A, Kerr C, Breheny K, Brazier J, Ortiz A & Borg E (2013) . Quality of Life Research, 1-10.
  • Viney R, Norman R, Cronin P, Brazier J, King MT, Ratcliffe J & Street D (2013) . Health Economics (United Kingdom).
  • Lu G, Brazier JE & Ades AE (2013) . Value in Health, 16(1), 177-184.
  • Mulhern B, Longworth L, Brazier J, Rowen D, Bansback N, Devlin N & Tsuchiya A (2013) . Value Health, 16(1), 104-113.
  • Mavranezouli I, Brazier JE, Rowen D & Barkham M (2013) . Med Decis Making, 33(3), 381-395.
  • Rowen D, Young T, Brazier J & Gaugris S (2012) . Value Health, 15(8), 1059-1068.
  • Connell J, Brazier J, O'Cathain A, Lloyd-Jones M & Paisley S (2012) . Health Qual Life Outcomes, 10, 138.
  • Brazier JA, Shah A & Brown GD (2012) . Chemical Communications, 48(87), 10739-10739.
  • Norman R, Brazier JE, Viney R, Burgess L, Cronin P, King MT, Ratcliffe J & Street D (2012) Revaluing the SF-6D using ordinal methods for eliciting preferences. QUALITY OF LIFE RESEARCH, 21, 6-6.
  • Brazier J, Mulhern B, Alonso J, Connell J, Papaioannou D & Vilagut G (2012) Are generic preference-based measures valid in mental health? A mixed methods enquiry. QUALITY OF LIFE RESEARCH, 21, 1-1.
  • Kazis LE, Selim AJ, Rogers W, Qian SX & Brazier J (2012) Monitoring outcomes for the Medicare Advantage program: methods and application of the VR-12 for evaluation of plans.. The Journal of ambulatory care management, 35(4), 263-276.
  • Browne C, Brazier J, Carlton J, Alavi Y & Jofre-Bonet M (2012) . Eye (Basingstoke), 26(10), 1295-1301.
  • Kazis LE, Selim AJ, Rogers W, Qian SX & Brazier J (2012) . J Ambul Care Manage, 35(4), 263-276.
  • Mulhern B, Brazier JE, Rowen D, Young TA, Smith SC & Banerjee S (2012) . Value Health, 15(5), 787-788.
  • Brazier JE, Rowen D, Mavranezouli I, Tsuchiya A, Young T, Yang Y, Barkham M & Ibbotson R (2012) . Health Technol Assess, 16(32), 1-114.
  • Brazier JS (2012) . Anaerobe, 18(2), 197-199.
  • Netten A, Burge P, Malley J, Potoglou D, Towers A-M, Brazier J, Flynn T, Forder J & Wall B (2012) . HEALTH TECHNOLOGY ASSESSMENT, 16(16), 1-+.
  • Malley JN, Towers A-M, Netten AP, Brazier JE, Forder JE & Flynn T (2012) . HEALTH AND QUALITY OF LIFE OUTCOMES, 10.
  • Bansback N, Tsuchiya A, Brazier J & Anis A (2012) . PLOS ONE, 7(2).
  • Mukuria C & Brazier J (2012) . Social Science and Medicine.
  • Ratcliffe J, Stevens K, Flynn T, Brazier J & Sawyer MG (2012) . Value in Health, 15(5), 730-736.
  • Mulhern B, Smith SC, Rowen D, Brazier JE, Knapp M, Lamping DL, Loftus V, Young TA, Howard RJ & Banerjee S (2012) . Value in Health, 15(2), 323-333.
  • Rowen D, Mulhern B, Banerjee S, Van Hout B, Young TA, Knapp M, Smith SC, Lamping DL & Brazier JE (2012) . Value in Health, 15(2), 346-356.
  • Ratcliffe J, Flynn T, Terlich F, Stevens K, Brazier J & Sawyer M (2012) . PharmacoEconomics, 30(8), 713-727.
  • Kerr C, Lloyd A, Rowen D, Maslen T & Brazier J (2012) . Health Outcomes Research in Medicine, 3(3).
  • Mulhern B, Rowen D, Jacoby A, Marson T, Snape D, Hughes D, Latimer N, Baker GA & Brazier JE (2012) . Epilepsy and Behavior, 24(1), 36-43.
  • Tosh J, Brazier J, Evans P & Longworth L (2012) . Value Health, 15(1), 118-127.
  • Bansback N, Brazier J, Tsuchiya A & Anis A (2012) . J Health Econ, 31(1), 306-318.
  • Tilling C, Krol M, Tsuchiya A, Brazier J, Exel JV & Brouwer W (2012) . Pharmacoeconomics, 30(1), 47-61.
  • Ara R & Brazier J (2012) . Med Care, 50(5), 452-459.
  • McTaggart-Cowan HM, O'Cathain A, Tsuchiya A & Brazier JE (2012) . Qual Life Res, 21(3), 465-473.
  • Rowen D, Brazier J, Tsuchiya A, Young T & Ibbotson R (2012) . Med Decis Making, 32(1), 31-40.
  • Rowen D, Brazier J, Tsuchiya A & Alava MH (2012) . Health Economics, 21(6), 715-729.
  • Burton M, Walters SJ, Saleh M & Brazier JE (2012) . Qual Life Res, 21(10), 1731-1743.
  • Brazier J, Rowen D, Yang Y & Tsuchiya A (2012) . Eur J Health Econ, 13(5), 575-587.
  • Lloyd A, Hodgkins P, Sasane R, Akehurst R, Sonuga-Barke EJS, Fitzgerald P, Nixon A, Erder H & Brazier J (2011) . PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 4(4), 247-257.
  • Salhiyyah K, Elsobky S, Raja S, Attia R, Brazier J & Cooper GJ (2011) . Heart Surg Forum, 14(6), E330-E334.
  • Mutebi A, Brazier JE & Walters SJ (2011) . QUAL LIFE RES, 20(9), 1477-1486.
  • Selim AJ, Rogers W, Qian SX, Brazier J & Kazis LE (2011) . QUAL LIFE RES, 20(8), 1337-1347.
  • Papaioannou D, Brazier J & Parry G (2011) . Value Health, 14(6), 907-920.
  • Rowen D, Brazier J, Young T, Gaugris S, Craig BM, King MT & Velikova G (2011) . Value Health, 14(5), 721-731.
  • Ara R & Brazier J (2011) . Value Health, 14(5), 740-745.
  • Ara R & Brazier JE (2011) . Value Health, 14(4), 539-545.
  • Matza LS, Van Brunt K, Chung K, Brazier J, Braun AH, Currie B & Body J (2011) Health state utilities for skeletal-related events associated with bone metastases.. J Clin Oncol, 29(15_suppl), e16620.
  • Matza LS, Van Brunt K, Chung K, Brazier J, Braun AH, Currie B & Body J (2011) . JOURNAL OF CLINICAL ONCOLOGY, 29(15).
  • Potoglou D, Burge P, Flynn T, Netten A, Malley J, Forder J & Brazier JE (2011) . SOC SCI MED, 72(10), 1717-1727.
  • McTaggart-Cowan H, Tsuchiya A, O'Cathain A & Brazier J (2011) . Soc Sci Med, 72(11), 1904-1912.
  • Yang Y, Brazier JE, Tsuchiya A & Young TA (2011) . Med Decis Making, 31(2), 281-291.
  • McGhee SM, Brazier J, Lam CLK, Wong LC, Chau J, Cheung A & Ho A (2011) Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(6 SUPPL 6), 17-21.
  • Schwenkglenks M, Brazier JE, Szucs TD & Fox KAA (2011) . VALUE IN HEALTH, 14(1), 24-33.
  • Ratcliffe J, Stevens K, Flynn T, Brazier J & Sawyer M (2011) An assessment of the construct validity of the CHU9D in the Australian adolescent general population. Quality of Life Research, 1-9.
  • McTaggart-Cowan HM, O'Cathain A, Tsuchiya A & Brazier JE (2011) Using mixed methods research to explore the effect of an adaptation exercise on general population valuations of health states. Quality of Life Research, 1-9.
  • Cruz LN, Camey SA, Hoffmann JF, Rowen D, Brazier JE, Fleck MP & Polanczyk CA (2011) . Value in Health, 14(5 SUPPL.).
  • Kowalski JW, Rentz AM, Walt JG, Lloyd A, Lee J, Young TA, Chen W-H, Bressler NM, Lee P, Brazier JE , Hays RD et al (2011) Rasch analysis in the development of a simplified version of the national eye institute visual-function questionnaire-25 for utility estimation. Quality of Life Research, 1-12.
  • Brazier J, Rowen D, Tsuchiya A, Yang Y & Young TA (2011) . Soc Sci Med, 73(2), 245-253.
  • Mavranezouli I, Brazier JE, Young TA & Barkham M (2011) . Quality of Life Research, 20(3), 321-333.
  • Young TA, Yang Y, Brazier JE & Tsuchiya A (2011) . Med Decis Making, 31(1), 195-210.
  • Ratcliffe J, Couzner L, Flynn T, Sawyer M, Stevens K, Brazier J & Burgess L (2011) . Applied Health Economics and Health Policy, 9(1), 15-27.
  • Ferreira LN, Ferreira PL, Rowen D & Brazier JE (2011) . Qual Life Res, 20(4), 609-619.
  • Versteegh MM, Rowen D, Brazier JE & Stolk EA (2010) . Health Qual Life Outcomes, 8, 141.
  • Lloyd A, Kerr C, Rowen D, Maslen T & Brazier J (2010) . Value in Health, 13(7), A380-A381.
  • Szende A, Schaefer C & Brazier J (2010) . Value in Health, 13(7), a472.
  • Brazier J (2010) Developing preference-based measures from existing quality of life measures: why, how and should we?. QUALITY OF LIFE RESEARCH, 19, 2-2.
  • Clauser SB, Brazier J, Feeny D, Revicki DA & Kind P (2010) Development and Comparisons of Alternative Preference-Based Measures of Health. QUALITY OF LIFE RESEARCH, 19, 2-2.
  • Peasgood T, Ward SE & Brazier J (2010) . Expert Rev Pharmacoecon Outcomes Res, 10(5), 553-566.
  • Palfreyman SJ, Tod AM, Brazier JE & Michaels JA (2010) . J Clin Nurs, 19(19-20), 2673-2703.
  • Szende A, Brazier J, Schaefer C, Deuson R, Isitt JJ & Vyas P (2010) . CURR MED RES OPIN, 26(8), 1893-1903.
  • Cunillera O, Tresserras R, Rajmil L, Vilagut G, Brugulat P, Herdman M, Mompart A, Medina A, Pardo Y, Alonso J , Brazier J et al (2010) . QUAL LIFE RES, 19(6), 853-864.
  • Kharroubi SA, O'Hagan A & Brazier JE (2010) . STAT MED, 29(15), 1622-1634.
  • Ferreira LN, Ferreira PL, Pereira LN, Brazier J & Rowen D (2010) . VALUE HEALTH, 13(5), 624-630.
  • McTaggart-Cowan HM, Brazier JE & Tsuchiya A (2010) . Value Health, 13(6), 787-795.
  • Thorpe L, Thomas K, Fitter M, Brazier J, MacPherson H, Campbell M, Nicholl J, Morgan A & Roman M (2010) . Focus on Alternative and Complementary Therapies, 7(1), 113-113.
  • Thomas K, Fitter M, Brazier J, MacPherson H, Campbell M, Nicholl J, Thorpe L, Morgan A & Roman M (2010) . Focus on Alternative and Complementary Therapies, 6(1), 93-94.
  • Young TA, Rowen D, Norquist J & Brazier JE (2010) . Qual Life Res, 19(6), 907-917.
  • Brazier JE, Yang Y, Tsuchiya A & Rowen DL (2010) . Eur J Health Econ, 11(2), 215-225.
  • Ara R & Brazier JE (2010) . Value Health, 13(5), 509-518.
  • Palfreyman SJ, Shackley P & Brazier JE (2010) . J CLIN NURS, 19(5-6), 892-897.
  • Brazier J & Tsuchiya A (2010) . HEALTH ECON, 19(2), 125-129.
  • Hind D, Scott EJ, Copeland R, Breckon JD, Crank H, Walters SJ, Brazier JE, Nicholl J, Cooper C & Goyder E (2010) . BMC Public Health, 10, 3.
  • Tilling C, Krol M, Tsuchiya A, Brazier J & Brouwer W (2010) . Value Health, 13(2), 298-305.
  • Brazier JE, Fukuhara S, Roberts J, Kharroubi S, Yamamoto Y, Ikeda S, Doherty J & Kurokawa K (2009) . J Clin Epidemiol, 62(12), 1323-1331.
  • Ratcliffe J, Brazier J, Tsuchiya A, Symonds T & Brown M (2009) . HEALTH ECON, 18(11), 1261-1276.
  • Pyne JM, Fortney JC, Tripathi S, Feeny D, Ubel P & Brazier J (2009) . HEALTH SERV RES, 44(4), 1406-1423.
  • Peasgood T, Herrmann K, Kanis JA & Brazier JE (2009) . Osteoporos Int, 20(6), 853-868.
  • Stein K, Dyer M, Milne R, Round A, Ratcliffe J & Brazier J (2009) . QUAL LIFE RES, 18(4), 509-518.
  • Czoski-Murray C, Carlton J, Brazier J, Young T, Papo NL & Kang HK (2009) . Value Health, 12(5), 793-799.
  • Mann R, Brazier J & Tsuchiya A (2009) . Health Econ, 18(3), 363-372.
  • Young T, Yang Y, Brazier JE, Tsuchiya A & Coyne K (2009) . Qual Life Res, 18(2), 253-265.
  • Rowen D, Brazier J & Roberts J (2009) . Health Qual Life Outcomes, 7, 27.
  • Brazier JE, Dixon S & Ratcliffe J (2009) . Pharmacoeconomics, 27(9), 705-712.
  • Ara R & Brazier J (2009) . Value in Health, 2(12), 346-353.
  • Ara R & Brazier J (2008) . Value Health, 11(7), 1131-1143.
  • Brazier J (2008) . J Health Serv Res Policy, 13 Suppl 3, 70-75.
  • McKenna SP, Ratcliffe J, Meads DM & Brazier JE (2008) . HEALTH QUAL LIFE OUT, 6.
  • Bansback N, Harrison M, Brazier J, Davies L, Kopec J, Marra C, Symmons D & Anis A (2008) . ARTHRIT RHEUM-ARTHR, 59(7), 1018-1026.
  • Bevan G & Brazier J (2008) . Financial Accountability and Management, 1(2), 173-189.
  • (2008) . Nucleosides Nucleotides & Nucleic Acids, 27(4), 431-431.
  • McTaggart-Cowan HM, Marra CA, Yang Y, Brazier JE, Kopec JA, FitzGerald JM, Anis AH & Lynd LD (2008) . QUAL LIFE RES, 17(3), 453-462.
  • Lam CLK, Brazier J & McGhee SM (2008) . VALUE HEALTH, 11(2), 295-303.
  • Noronha Ferreira L, Lopes Ferreira P, Nobre Pereira L & Brazier J (2008) . Journal of Medical Economics, 11(2), 215-233.
  • Brazier J (2008) . Pharmacoeconomics, 26(9), 769-779.
  • Brazier J, Czoski-Murray C, Roberts J, Brown M, Symonds T & Kelleher C (2008) . Med Decis Making, 28(1), 113-126.
  • Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J & Madan J (2007) A review and critique of modelling in prioritising and designing screening programmes.. Health technology assessment (Winchester, England), 11(52).
  • Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J & Madan J (2007) A review and critique of modelling in prioritising and designing screening programmes. HEALTH TECHNOL ASSES, 11(52), 1-+.
  • Reuber M, Burness C, Howlett S, Brazier J & Grünewald R (2007) . J Psychosom Res, 63(6), 625-632.
  • Bansback N, Davis S & Brazier J (2007) . Eye (Lond), 21(12), 1455-1463.
  • Stevens K, McCabe C, Brazier J & Roberts J (2007) . J Health Econ, 26(5), 992-1002.
  • Bansback N, Marra C, Tsuchiya A, Anis A, Guh D, Hammond T & Brazier J (2007) . ARTHRIT RHEUM-ARTHR, 57(6), 963-971.
  • Brazier J & Tsuchiya A (2007) The Role of Condition Specific Measures in Economic Evaluation: It's a Trade-Off.
  • Palfreyman SJ, Tod AM, King B, Tomlinson D, Brazier JE & Michaels JA (2007) . J Adv Nurs, 58(5), 458-467.
  • Kharroubi SA, Brazier JE, Roberts J & O'Hagan A (2007) . J HEALTH ECON, 26(3), 597-612.
  • Ratcliffe J, Brazier J, Palfreyman S & Michaels J (2007) . Health Econ, 16(4), 395-405.
  • Bansback N, Czoski-Murray C, Carlton J, Lewis G, Hughes L, Espallargues M, Brand C & Brazier J (2007) . Qual Life Res, 16(3), 533-543.
  • Kharroubi S, Brazier JE & O'Hagan A (2007) . SOC SCI MED, 64(6), 1242-1252.
  • Stevens K, McCabe C & Brazier J (2007) Response to Shmueli. Health Economics, 16(7), 759-761.
  • Palfreyman S, Michaels J & Brazier J (2007) . Nursing Standard, 21(45), 57-69.
  • Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M & Brazier J (2007) . J Health Serv Res Policy, 12(1), 56-58.
  • Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J & Madan J (2007) A review and critique of modelling in prioritising and designing screening programmes.. Health technology assessment (Winchester, England), 11(52).
  • Tappenden P, Brazier J, Ratcliffe J & Chilcott J (2007) . Pharmacoeconomics, 25(8), 685-693.
  • McCloskey EV, Beneton M, Charlesworth D, Kayan K, deTakats D, Dey A, Orgee J, Ashford R, Forster M, Cliffe J , Kersh L et al (2007) . J Bone Miner Res, 22(1), 135-141.
  • Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M & Brazier J (2007) . Journal of Health Services Research and Policy, 12(3), 190-191.
  • Stein K, Dyer M, Crabb T, Milne R, Round A, Ratcliffe J & Brazier J (2006) . HEALTH QUAL LIFE OUT, 4.
  • Ratcliffe J, Thomas KJ, MacPherson H & Brazier J (2006) . BMJ, 333(7569), 626.
  • Thomas KJ, MacPherson H, Thorpe L, Brazier J, Fitter M, Campbell MJ, Roman M, Walters SJ & Nicholl J (2006) . BMJ, 333(7569), 623.
  • Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G & Sutcliffe P (2006) . Health Technol Assess, 10(33), iii-168.
  • Brazier J, Tumur I, Holmes M, Ferriter M, Parry G, Dent-Brown K & Paisley S (2006) . Health Technol Assess, 10(35), iii-117.
  • McCabe C, Stevens K, Roberts J & Brazier J (2006) . Health Economics, 15(7), 761-761.
  • Brazier J, Dolan P, Karampela K & Towers I (2006) . Health Econ, 15(6), 543-551.
  • McCabe C, Brazier J, Gilks P, Tsuchiya A, Roberts J, O'Hagan A & Stevens K (2006) . J Health Econ, 25(3), 418-431.
  • Michales JA, Campbell WB, Brazier JE, MacIntyre JB, Palfreyman SJ, Ratcliffe J & Rigby K (2006) Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). HEALTH TECHNOL ASSES, 10(13), III-+.
  • Stein K, Ratcliffe J, Round A, Milne R & Brazier JE (2006) . HEALTH QUAL LIFE OUT, 4.
  • Tsuchiya A, Brazier J & Roberts J (2006) . J Health Econ, 25(2), 334-346.
  • Ratcliffe J, Brazier JE, Campbell WB, Palfreyman S, MacIntyre JB & Michaels JA (2006) . Br J Surg, 93(2), 182-186.
  • Michaels JA, Brazier JE, Campbell WB, MacIntyre JB, Palfreyman SJ & Ratcliffe J (2006) . Br J Surg, 93(2), 175-181.
  • Claxton K, Sculpher M, Culyer A, McCabe C, Briggs A, Akehurst R, Buxton M & Brazier J (2006) . Health Econ, 15(1), 1-4.
  • Espallargues M, Czoski-Murray CJ, Bansback NJ, Carlton J, Lewis GM, Hughes LA, Brand CS & Brazier JE (2005) . Invest Ophthalmol Vis Sci, 46(11), 4016-4023.
  • Elliott SL, Brazier J, Cosstick R & Connolly BA (2005) . J Mol Biol, 353(3), 692-703.
  • Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S & Nicholl JP (2005) Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.. Health technology assessment (Winchester, England), 9(32).
  • Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S & Nicholl JP (2005) . Health Technol Assess, 9(32), iii-109.
  • Walters SJ & Brazier JE (2005) . Qual Life Res, 14(6), 1523-1532.
  • Stevens KJ, Brazier JE, McKenna SP, Doward LC & Cork MJ (2005) . Br J Dermatol, 153(2), 372-377.
  • Towers I, Spencer A & Brazier J (2005) . Expert Rev Pharmacoecon Outcomes Res, 5(3), 245-254.
  • Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM, Brazier JE, Fortin PR & Anis AH (2005) . QUAL LIFE RES, 14(5), 1333-1344.
  • McCabe CJ, Stevens KJ & Brazier JE (2005) . Med Care, 43(6), 627-635.
  • Kharroubi SA, O'Hagan A & Brazier JE (2005) Estimating utilities from individual health preference data: a nonparametric Bayesian method. J ROY STAT SOC C-APP, 54, 879-895.
  • Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J & O'Hagan T (2005) . HEALTH ECON, 14(4), 339-347.
  • Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM & Anis AH (2005) . SOC SCI MED, 60(7), 1571-1582.
  • McCabe C, Stevens K, Roberts J & Brazier J (2005) . Health Econ, 14(3), 231-244.
  • Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2005) Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women. J OPER RES SOC, 56(2), 214-221.
  • Stein K, Fry A, Round A, Milne R & Brazier J (2005) . Applied Health Economics and Health Policy, 4(4), 219-228.
  • Hibbert CL, Coates EJ, Brazier JE & Morris J (2005) A cost survey of 70 adult critical care units - Results from a volunteer sample in England, Scotland and Northern Ireland in 2003. Care of the Critically Ill, 21(1), 8-17.
  • Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S & Nicholl JP (2005) Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.. Health technology assessment (Winchester, England), 9(32).
  • Brazier J, Akehurst R, Brennan A, Dolan P, Claxton K, McCabe C, Sculpher M & Tsuchyia A (2005) . Appl Health Econ Health Policy, 4(4), 201-208.
  • Brazier JE, Roberts J, Platts M & Zoellner YF (2005) . Health Qual Life Outcomes, 3, 13.
  • Munro JF, Nicholl JP, Brazier JE, Davey R & Cochrane T (2004) . J Epidemiol Community Health, 58(12), 1004-1010.
  • Littlejohns P, Leng G, Culyer T & Drummond M (2004) . BMJ, 329(7465), 571.1-571.1.
  • Hatoum HT, Brazier JE & Akhras KS (2004) Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. VALUE HEALTH, 7(5), 602-609.
  • Brazier J, Roberts J, Tsuchiya A & Busschbach J (2004) . Health Econ, 13(9), 873-884.
  • Brazier JE & Roberts J (2004) . Med Care, 42(9), 851-859.
  • Brazier JE, Kolotkin RL, Crosby RD & Williams GR (2004) . Value Health, 7(4), 490-498.
  • Littlejohns P, Leng G, Culyer T, Drummond M, Pilling S, Dutchak J, McInnes E, Macbeth F, Pearson M, Thomas J , Turnbull N et al (2004) NICE clinical guidelines [2] (multiple letters). British Medical Journal, 329(7465), 571-572.
  • Wailoo A, Roberts J, Brazier J & McCabe C (2004) . British Medical Journal, 328(7439), 536-537.
  • Simren M, Brazier J, Coremans G, Dapoigny M, Muller-Lissner SA, Pace F, Smout AJPM, Stockbrugger RW, Vatn MH & Whorwell PJ (2004) . DIGESTION, 69(4), 254-261.
  • Krabbe PFM, Adang EMM, Stalmeier PFM, Schackman BR, Brazier J & Weinstein MC (2003) . Medical Decision Making, 23(6), 542-543.
  • O'Brien BJ, Spath M, Blackhouse G, Severens JL, Dorian P & Brazier J (2003) . HEALTH ECON, 12(11), 975-981.
  • Brazier J, Green C, McCabe C & Stevens K (2003) . Expert Rev Pharmacoecon Outcomes Res, 3(3), 293-302.
  • Paterson C, Ewings P, Brazier JE & Britten N (2003) . COMPLEMENT THER MED, 11(2), 78-84.
  • Walters SJ & Brazier JE (2003) . Health Services and Outcomes Research Methodology, 4(1), 35-47.
  • Walters SJ & Brazier JE (2003) . Health Qual Life Outcomes, 1, 4.
  • Brazier JE, Green C, Kanis JA & Committee Of Scientific Advisors International Osteoporosis Foundation (2002) . Osteoporos Int, 13(10), 768-776.
  • Macpherson H, Thomas K, Brazier J, Fitter M, Thorpe L, Campbell M, Nicholl J, Roman M & Morgan A (2002) . Acupuncture in Medicine, 20(2-3), 121-137.
  • Robinson J, Brazier J & Beard J (2002) Patient-determined quality of life measure in critical limb ischaemia. BRIT J SURG, 89(4), 526-526.
  • Brazier J, Roberts J & Deverill M (2002) . J Health Econ, 21(2), 271-292.
  • Kanis JA, Brazier JE, Stevenson M, Calvert NW & Lloyd Jones M (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis.. Health technology assessment (Winchester, England), 6(29), 1-146.
  • Kanis JA, Brazier JE, Stevenson M, Calvert NW & Jones ML (2002) Treatment of established osteoporosis: A systematic review and cost-utility analysis. Health Technology Assessment, 6(29).
  • Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J & Weinstein MC (2002) Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. MED DECIS MAKING, 22(1), 27-38.
  • Brazier J & Fitzpatrick R (2002) . Health Econ, 11(1), 17-19.
  • Kanis JA, Brazier JE, Stevenson M, Calvert NW & Lloyd Jones M (2002) . Health Technol Assess, 6(29), 1-146.
  • Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, Platts M & Walters SJ (2002) . Pharmacoeconomics, 20(7), 455-462.
  • Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J & Weinstein MC (2001) . Value in Health, 4(2), 130-130.
  • Crawford B & Brazier JE (2001) . Value in Health, 4(2), 71-71.
  • Crawford B, Brazier JE, Strand V & Doyle J (2001) . Value in Health, 4(2), 71-71.
  • Brazier JE, Green C & Kanis J (2001) . Value in Health, 4(2), 64-64.
  • Hatoum H, Brazier J, Akhras K, Boyer J & Tooley J (2001) . Value in Health, 4(6), 408.
  • Walters SJ, Munro JF & Brazier JE (2001) . Age Ageing, 30(4), 337-343.
  • Michaels JA, Campbell WB, Rigby KA, Chan P, Beard J, Wood R, Lonsdale RJ, Sheriff S, Palfreyman S, Thompson J , Allington K et al (2001) . Phlebology: The Journal of Venous Disease, 16(1), 29-33.
  • Brazier JE & Johnson AG (2001) . Lancet, 358(9287), 1077-1081.
  • Morgan A, Shackley P, Pickin M & Brazier J (2000) . J Health Serv Res Policy, 5(4), 214-218.
  • Cotton L, Brazier J, Hall DM, Lindsay G, Marsh P, Polnay L & Williams TS (2000) . J Adv Nurs, 31(5), 1063-1071.
  • Michaels J, Palfreyman S, Shackley P, Slack R & Brazier J (2000) . British Journal of Surgery, 87(4), 515-515.
  • Green C, Brazier J & Deverill M (2000) . Pharmacoeconomics, 17(2), 151-165.
  • Akehurst R, Anderson P, Brazier JE, Brennan A, Briggs , Buxton M & et al (2000) Decision analytic modelling in the economics evaluation of health care technologies: a consensus statement. PharmacoEconomics(4), 161-163.
  • Brazier JE (2000) Decision Analytic modelling in the Economic Evaluation of Health Technologies: A consensus statement. PharmacoEconomics, 5(17), 443-444.
  • Michaels J, Brazier J, Palfreyman S, Shackley P & Slack R (2000) . Health Technology Assessment, 4(11).
  • Brazier JE, Harper R, Munro J, Walters SJ & Snaith ML (1999) . Rheumatology (Oxford), 38(9), 870-877.
  • Brazier J, Deverill M & Green C (1999) . J Health Serv Res Policy, 4(3), 174-184.
  • Dixon S, Deverill M, Gannon M, Brazier J & Haggard M (1999) . J Health Serv Res Policy, 4(3), 161-163.
  • Thomas KJ, Fitter M, Brazier J, MacPherson H, Campbell M, Nicholl JP & Roman M (1999) . Complement Ther Med, 7(2), 91-100.
  • Brazier J & Deverill M (1999) A checklist for judging preference-based measures of health related quality of life: learning from psychometrics.. Health Econ, 8(1), 41-51.
  • Brazier J, Deverill M, Green C, Harper R & Booth A (1999) . Health Technology Assessment, 3(9).
  • Wight JP, Edwards L, Brazier J, Walters S, Payne JN & Brown CB (1998) . Qual Health Care, 7(4), 209-221.
  • Keller SD, Ware JE, Bentler PM, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Kaasa S , Leplege A et al (1998) Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1179-1188.
  • Gandek B, Ware JE, Aaronson NK, Alonso J, Apolone G, Bjorner J, Brazier J, Bullinger M, Fukuhara S, Kaasa S , Leplege A et al (1998) Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1149-1158.
  • Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A , Prieto L et al (1998) The factor structure of the SF-36 Health Survey in 10 countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1159-1165.
  • Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L , Sullivan M et al (1998) The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1167-1170.
  • Raczek AE, Ware JE, Bjorner JB, Gandek B, Haley SM, Aaronson NK, Apolone G, Bech P, Brazier JE, Bullinger M & Sullivan M (1998) Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1203-1214.
  • Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L & Sullivan M (1998) Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1171-1178.
  • Brazier J, Usherwood T, Harper R & Thomas K (1998) . J Clin Epidemiol, 51(11), 1115-1128.
  • Deverill M, Brazier J, Green C & Booth A (1998) . Pharmacoeconomics, 13(4), 411-420.
  • Keller SD, Ware JE, Gandek B, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Fukuhara S , Kaasa S et al (1998) . Journal of Clinical Epidemiology, 51(11), 933-944.
  • Munro J, Brazier J, Davey R & Nicholl J (1997) . J Public Health Med, 19(4), 397-402.
  • Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NM & Howard P (1997) . Thorax, 52(10), 879-887.
  • McCabe CJ, Thomas KJ, Brazier JE & Coleman P (1996) . Br J Psychiatry, 169(4), 516-521.
  • Brazier J, Nicholl J & Snooks H (1996) . J Health Serv Res Policy, 1(4), 232-237.
  • Brazier JE, Walters SJ, Nicholl JP & Kohler B (1996) . Qual Life Res, 5(2), 195-204.
  • Snooks HA, Nicholl JP, Brazier JE & Lees-Mlanga S (1996) . J Public Health Med, 18(1), 67-77.
  • McCloskey E, Luchetti M, Bernard J, deTakats D, Brazier J, Nicholl J & Kanis J (1996) . Osteoporosis International, 6(S1), 271-271.
  • Alexander W, Bradley C, Brazier J, Campbell K, Chadwick J, Clements D, Hall G, Mackinnon M, McLeod C, Miles K , Roberts S et al (1996) The report of the Clinical Care Group. Diabetic Medicine, 13(SUPPL. 4).
  • Nicholl J, Snooks H & Brazier J (1995) . BMJ, 311(7013), 1166-1166.
  • Nicholl JP, Brazier JE & Snooks HA (1995) . BMJ, 311(6999), 217-222.
  • Brazier J & Dixon S (1995) . Health Econ, 4(4), 255-264.
  • Brazier J (1995) . Pharmacoeconomics, 7(5), 403-415.
  • Bowling A & Brazier J (1995) . Social Science & Medicine, 41(10), 1337-1338.
  • NICHOLL J, SNOOKS H & BRAZIER J (1995) EFFECTS OF HELICOPTER SERVICE ON SURVIVAL AFTER TRAUMA - REPLY. BRIT MED J, 311(7013), 1166-1166.
  • WARE JE, KELLER SD, GANDEK B, BRAZIER JE & SULLIVAN M (1995) EVALUATING TRANSLATIONS OF HEALTH-STATUS QUESTIONNAIRES - METHODS FROM THE IQOLA PROJECT. INT J TECHNOL ASSESS, 11(3), 525-551.
  • Lowy A, Brazier J, Fall M, Thomas K, Jones N & Williams BT (1994) Quality of minor surgery by general practitioners in 1990 and 1991.. Br J Gen Pract, 44(385), 364-365.
  • Nicholl JP, Beeby NR & Brazier JE (1994) . Injury, 25(3), 145-153.
  • Nicholl JP, Coleman P & Brazier JE (1994) . Pharmacoeconomics, 5(2), 109-122.
  • Nicholl JP, Ross B, Milner PC, Brazier JE, Westlake L, Kohler B, Frost E, Williams BT & Johnson AG (1994) . Gut, 35(9), 1294-1300.
  • WARE JE, GANDEK B, AARONSON NK, ACQUADRO C, ALONSO J, APOLONE G, BECH P, BRAZIER J, BULLINGER M, FUKUHARA S , KAASA S et al (1994) THE SF-36 HEALTH SURVEY - DEVELOPMENT AND USE IN MENTAL-HEALTH RESEARCH AND THE IQOLA PROJECT. INT J MENT HEALTH, 23(2), 49-73.
  • Nicholl J, Brazier J & Beeby N (1994) . Injury, 25(10), 690.
  • Brazier J (1993) . Health Econ, 2(3), 213-215.
  • Lowy A, Brazier J, Fall M, Thomas K, Jones N & Williams BT (1993) . BMJ, 307(6901), 413-417.
  • Murmu LR (1993) Laparoscopic versus mini-incision cholecystectomy.. Lancet, 341(8836), 47-48.
  • Brazier J (1992) . Health Economics, 1(3), 208-209.
  • Gompertz P, Harwood R, Ebrahim S & Dickinson E (1992) . BMJ, 305(6854), 645-646.
  • Brazier J, Harper R, Jones N, Thomas K, Westlake L & Usherwood T (1992) . BMJ, 305(6854), 646-646.
  • Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T & Westlake L (1992) . BMJ, 305(6846), 160-164.
  • Triger DR, Johnson AG, Brazier JE, Johnston GW, Spencer EFA, McKee R, Anderson JR & Carter DC (1992) . Gut, 33(11), 1553-1558.
  • Nicholl JP, Brazier JE, Milner PC, Westlake C, Kohler B, Williams BT, Ross B, Frost E & Johnson AG (1992) . The Lancet, 340(8823), 801-807.
  • O'Cathain A, Brazier JE, Milner PC & Fall M (1992) Cost effectiveness of minor surgery in general practice: a prospective comparison with hospital practice.. Br J Gen Pract, 42(354), 13-17.
  • George S & Brazier J (1991) Information needs in a provider market: a case-study of ENT.. J Public Health Med, 13(2), 108-114.
  • Page H & Brazier J (1991) The funding debate revisited: who's for the mixed economy?. Health Serv Manage, 87(2), 84-86.
  • BRAZIER JE & NORMAND CEM (1991) AN ECONOMIC-REVIEW OF THE NHS WHITE PAPER. SCOT J POLIT ECON, 38(1), 96-105.
  • Bromwich P, Walker A, Dalton M, Lilford RJ, Page H, Brazier J, Edwards RG, Brinsden P, Elder K, Lewis P , Macnamee M et al (1989) . The Lancet, 334(8675), 1327-1329.
  • Milner PC, Brazier JE, Nicholl JP, Ross B & Johnson AG (1989) . The Lancet, 334(8653), 51.
  • Brazier J (1987) . Br Med J (Clin Res Ed), 295(6603), 898-900.
  • Bevan G & Brazier J (1987) . Br Med J (Clin Res Ed), 295(6602), 836-838.
  • Bevan G & Brazier J (1985) . Financial Accountability and Management, 1(2), 173-189.
  • Bevan G & Brazier J (1985) Moving resources. Subregional RAWP--Hobson's choice?. Health and social service journal, 95(4963), 1064-1065.
  • Brazier JE & Bevan G (1985) Equity and efficiency: clarifying the confusion for English acute hospitals.. Financial Accountability and Management, 2(1), 173-189.
  • Carlton J, Powell P, Rowen D, Broadley M, Pouwer F, Speight J, Heller S, Gall M-A, Rosilio M, Child C , Comins J et al () Producing a preference-based quality of life measure to quantify the impact of hypoglycaemia on people living with diabetes: a mixed-methods research protocol. Diabetic Medicine.
  • Saßmannshausen M, Behning C, Isselmann B, Schmid M, Finger RP, Holz FG, Schmitz-Valckenberg S, Pfau M, Agostini H, Altay L , Atia R et al () . Scientific Reports, 12(1).
  • Terheyden JH, Pondorfer SG, Behning C, Berger M, Carlton J, Rowen D, Bouchet C, Poor S, Luhmann UFO, Leal S , Holz FG et al () Disease-specific assessment of Vision Impairment in Low Luminance (VILL) in age-related macular degeneration – a MACUSTAR study report. British Journal of Ophthalmology.
  • Bansback N, Trenaman L, Mulhern BJ, Norman R, Metcalfe R, Sawatzky R, Brazier J, Rowen D & Whitehurst DGT () Estimation of a Canadian preference-based scoring algorithm for the Veterans RAND 12-item Health Survey (VR-12): a population survey using a discrete choice experiment. CMAJ open.
  • Pennington B, Alshreef A, Flight L, Metry A, Poku E, Hykin P, Sivaprasad S, Prevost AT, Vasconcelos JC, Murphy C , Kelly J et al () . PharmacoEconomics.
  • Peasgood T, Mukuria C, Carlton J, Connell J & Brazier J () . Quality of Life Research.
  • Powell P, Rowen D, Rivero-Arias O, Tsuchiya A & Brazier J () Valuing child and adolescent health: A qualitative study on different perspectives and priorities taken by the adult general public. Health and Quality of Life Outcomes.
  • Powell P, Carlton J, Rowen D, Brazier J, Facey K, Bayley K, Chandler F, Godfrey J & Crossley E () Measuring What Matters – Little Evidence Supporting the Content Validity of EQ-5D in People with Duchenne Muscular Dystrophy and Their Caregivers. Medical Decision Making.
  • Keetharuth AD, Bjorner JB, Barkham M, Browne J, Croudace T & Brazier J () . Quality of Life Research.
  • Whitehurst DGT, Brazier JE, Viney R & Mulhern BJ () . PharmacoEconomics.
  • Hykin P, Prevost AT, Sivaprasad S, Vasconcelos JC, Murphy C, Kelly J, Ramu J, Alshreef A, Flight L, Pennington R , Hounsome B et al () Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment.
  • Matza LS, Stewart KD, Lloyd A, Rowen D & Brazier J () Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations. Value in Health.
  • Rowen D, Powell P, Mukuria C, Carlton J, Norman R & Brazier J () Deriving a Preference-based Measure for People with Duchenne Muscular Dystrophy from the DMD-QoL. Value in Health.
  • Powell PA, Carlton J, Rowen D, Chandler F, Guglieri M & Brazier JE () . Neurology, 10.1212/WNL.0000000000011896-10.1212/WNL.000000000.
  • Peasgood T, Mukuria C, Carlton J, Connell J, Devlin N, Jones K, Lovett R, Naidoo B, Rand S, Rejon-Parrilla JC , Rowen D et al () What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality adjusted life years? Application to the development of the EQ-HWB?. European Journal of Health Economics.
  • Barkham M, Saxon D, Hardy GE, Bradburn M, Galloway D, Wickramasekera N, Keetharuth AD, Bower P, King M, Elliott R , Gabriel L et al () Clinical and cost-effectiveness of person-centred experiential therapy vs. cognitive behavioural therapy for moderate and severe depression delivered in the English Improving Access to Psychological Therapies national programme: A pragmatic randomised non- inferiority trial [PRaCTICED]. The Lancet Psychiatry.
  • McDool E, Mukuria C & Brazier J () . PharmacoEconomics.

Book chapters

  • Brazier J & Ratcliffe J (2017) , International Encyclopedia of Public Health (pp. 586-593). Elsevier
  • Ara R & Brazier J (2014) , Encyclopedia of Health Economics (pp. 130-138). Elsevier
  • Rowen D & Brazier J (2014) , Encyclopedia of Health Economics (pp. 358-365). Elsevier
  • Brazier J, Roberts J & Rowen D (2012) In Jones A (Ed.), The Elgar Companion to Health Economics, Second Edition (pp. 395-405).
  • Rowen D & Brazier J (2011) (pp. 787-813). Oxford University Press
  • Brazier J, Papaioannou D, Cantrell A, Paisley S & Herrmann K (2010) Identifying and reviewing health state utility values for populating decision models In Shemilt I, Mugford M, Vale L, Donaldson C & Marsh K (Ed.), Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice (pp. 93-105). Wiley-Blackwell
  • Brazier JE (2009) SF-6D In Kattan MW & Cowen ME (Ed.), Encyclopaedia of Medical Decision Making California: Sage Publications.
  • Brazier JE & Ratcliffe J (2008) The measurement and Valuation of Health for Economic Evaluation. In Heggenhougen HK & Quah S (Ed.), International Encyclopaedia of Public Health. (pp. 252-261). San Diego: Academic Press.
  • Brazier JE & Roberts J (2007) Methods for developing preference-based measures of Health. In Jones A (Ed.), The Elgar Companion to Health Economics (pp. 371-381). Cheltenham UK: Edward Elgar Publishing Ltd.
  • Jones M, Nardi B & Mynatt ED (2005) (pp. 147-148). Association for Computing Machinery (ACM)
  • Brazier J, Nicholl J & Snooks H (2004) , Studying the Organisation and Delivery of Health Services (pp. 176-187).
  • Brazier JE, Rice N & Roberts J (2002) Modelling health state valuation data In Murray C, Saloman J, Mathers C & Lopez A (Ed.), Summary Measures of Population Health 2002: Concepts, Ethics, Measurement and Applications (pp. 529-548). World Health Organisation
  • Brazier JE & Morgan A (2002) Economic evaluation of complementary therapies, Clinical Research in complementary therapies London: Churchill Livingstone.
  • Brazier JE, Deverill M & Green C (2001) The use of health related quality of life questionnaires in economic evaluation. In Stevens A, Abrams K, Brazier J, Fitzpatrick R & Lilford R (Ed.), Methods in Hdealth Technology Assessment London: Sage Books.
  • Brazier JE, Green G, Ormandy D & Gilbertson J (2000) Tolerant Building: The impact of energy efficiency measures on living conditions and health status In Rudge J & Nical F (Ed.), Cutting the cost of cold: Affordable warmth for healthier homes (pp. 87-106). London: Taylor & Francis.
  • Brazier JE & Deverill M (1998) The use of health related quality of life questionnaires in economic evaluation. In Black N, Fitzpatrick R & Reeves B (Ed.), Methods for Health Services Research: a state of the art guide. London: BMJ Books.
  • Brazier JE (1998) The SF-36 Health Survey and its use in Pharmacoeconomics economic evaluation., Quality of Life Assessment Auckland: Adis International.
  • Brazier JE & Green C (1996) Economic Evaluation in Brief In Earlam RJ (Ed.), The Royal Hospital Trauma Hospital - A Trauma Care System London.
  • Brazier JE, Williams BT & Nicholl J (1996) Health Care Needs Assessment: Accident and Emergency Departments. In Stevens A & Raftery J (Ed.), Health Care Needs Assessment Frome: Radlcliffe Medical Press.
  • Brazier JE & Cairns J (1996) An economic perspective on health outcome measurement. In Hutchinson & et al (Ed.), Outcome Measurement in Primary Care Amsterdam: Harwood academic publishers.
  • Brazier JE & Jeavons R (1991) The economics of diabetic care In Bradley C, Christine M & West R (Ed.), The technology of diabetic care London: Harwood.
  • Brazier JE, Hutton J & Jeavons R (1990) Evaluating the reform of the NHS In Culyer AJ, Maynard A & Posnett J (Ed.), Competition in Health Care: reforming the NHS London: MacMillan Press.
  • Brazier JE, Jeavons R & Akehurst R (1989) The White Paper and the NHS: How much competition will there actually be?, Health Care UK Newbury: Policy Journals.
  • Brazier JE (1988) District health authorities as trading organisations., Health Care UK Newbury: Policy Journals.

Conference proceedings

  • Kharroubi S, El Harakeh M, Dawoud D, Rowen D & Brazier JE (2022) . Value in Health, Vol. 25(7) (pp S574-S574)
  • Schneider P, Brazier JE, Devlin N & van Hout B (2022) . Value in Health, Vol. 25(7) (pp S546-S546)
  • Schneider P, Brazier J, Devlin N & Hout BV (2022) . Abstracts (pp a32.1-a3a32)
  • Kharroubi S, El Harakeh M, Dawoud D, Rowen D & Brazier JE (2022) VALUATION OF SF-6D HEALTH STATES: IS IT FEASIBLE AND ACCEPTABLE IN A LEBANESE POPULATION. VALUE IN HEALTH, Vol. 25(7) (pp S574-S574)
  • Schneider P, Brazier JE, Devlin N & van Hout B (2022) THE OPUF TOOL: A NEW TYPE OF ONLINE SURVEY FOR CREATING VALUE SETS FOR THE EQ-5D-5L ON THE SOCIETAL-, GROUP-, AND INDIVIDUAL PERSON LEVEL. VALUE IN HEALTH, Vol. 25(7) (pp S546-S546)
  • Broderick L, Lauher M, White MK, Kosinski M, Mulhern B, Brazier JE & Bjorner JB (2022) PARTICIPANT REINTERPRETATION OF HEALTH STATES: A THINK-ALOUD STUDY OF DECISION-MAKING STRATEGIES IN DISCRETE CHOICE EXPERIMENTS WITH THE SF-6DV2. VALUE IN HEALTH, Vol. 25(7) (pp S551-S551)
  • Holt R, Taylor S, Barretto N, Hirst A, Oliver L, Brandolini G & Brazier JE (2022) BRIDGING AND VALIDATION OF A THYROID EYE DISEASE (TED) SPECIFIC QUALITY OF LIFE (QOL) QUESTIONNAIRE TO UTILITY VALUES ASSESSED BY A TIME TRADE-OFF (TTO) ANALYSIS. VALUE IN HEALTH, Vol. 25(7) (pp S531-S531)
  • Schneider P, Van Hout B, Heisen M, Brazier J & Devlin N (2022) A NEW ONLINE TOOL FOR VALUING HEALTH STATES: ELICITING PERSONAL UTILITY FUNCTIONS FOR THE EQ-5D-5L. VALUE IN HEALTH, Vol. 25(1) (pp S13-S13)
  • Terheyden JH, Pondorfer SG, Behning C, Berger M, Rowen D, Carlton J, Holz FG, Butt T, Brazier JE & Finger RP (2021) Psychometric properties of the Vision Impairment in Low Luminance (VILL) questionnaire in age-related macular degeneration in the MACUSTAR study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 62(8)
  • Hartl K, Durno N, Schmid R, Heisen M, Ethgen O, Szilvasy Z, Friedel E, Wong O, Charman T, San Jose Caceres A , Muehlbacher A et al (2021) Preference Study in Childhood Autism Spectrum Disorder (ASD) using the Childhood Autism Rating Scale (CARS2): A Feasibility Assessment. QUALITY OF LIFE RESEARCH, Vol. 30(SUPPL 1) (pp S113-S114)
  • Broderick L, Bjorner J, Lauher M, Kosinski M, White MK, Mulhern B & Brazier JE (2021) DEVELOPMENT OF THE SF-6DV2 HEALTH UTILITY SURVEY: CONTENT VALIDITY AND PATIENT PREFERENCE. VALUE IN HEALTH, Vol. 24 (pp S193-S193)
  • Xie S, Wu J, He X, Chen G & Brazier JE (2020) . Value in Health, Vol. 23 (pp S319-S319)
  • Wu J, Xie S, He X, Chen G & Brazier JE (2020) . Value in Health, Vol. 23 (pp S325-S325)
  • Xie S, Wu J, He X, Chen G & Brazier JE (2020) TEST-RETEST RELIABILITY OF COMPOSITE TTO AND DCE WITH DURATION IN THE VALUATION OF SF-6DV2 HEALTH STATES. VALUE IN HEALTH, Vol. 23 (pp S319-S319)
  • Bansback N, Mulhern B, Norman R, Trenaman L, Metcalfe R, Sawatzky R, Brazier J, Rowen D & Whitehurst DGT (2020) DEVELOPMENT OF A PREFERENCE BASED SINGLE INDEX FOR THE VR-12 IN CANADA. MEDICAL DECISION MAKING, Vol. 40(1) (pp E53-E54)
  • Scarisbrick J, Schmidt F, Turini MM, D'agostino P, Thornton S, Evans J, Ader J, van Hest N & Brazier JE (2020) HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA PATIENTS: DETERMINATION OF UTILITY VALUES FROM A UK-BASED CLINICIAN QUESTIONNAIRE. VALUE IN HEALTH, Vol. 23 (pp S715-S715)
  • Schneider P, Van Hout B & Brazier J (2020) FAIR INTERPERSONAL UTILITY COMPARISON IN THE CONTEXT OF HEALTH VALUATION: DESCRIPTION AND FIRST EMPIRICAL EVALUATION OF A NEW MULTI-STEP PREFERENCE AGGREGATION PROCEDURE. MEDICAL DECISION MAKING, Vol. 40(5) (pp E407-E408)
  • Brazier J (2020) Extending the QALY (E-QALY): developing a new generic preference-based measure for use with patients, carers and those needing care-an overview. QUALITY OF LIFE RESEARCH, Vol. 29(SUPPL 1) (pp S3-S3)
  • Shah K, Bennett B, Lenny A, Longworth L, Brazier JE, Oppe M, Pickard AS & Shaw JW (2020) ADAPTING PREFERENCE-BASED UTILITY MEASURES TO CAPTURE THE IMPACT OF CANCER TREATMENT-RELATED SYMPTOMS. VALUE IN HEALTH, Vol. 23 (pp S430-S430)
  • Flight L, Alshreef A, Hykin PG, Sivaprasad S, Pennington B, Kelly J, Murphy CL & Brazier JE (2019) . Value in Health, Vol. 22(Suppl 3) (pp S664-S664). Copenhagen, Denmark, 2 November 2019 - 6 November 2019.
  • Keetharuth A, Brazier JE, Rowen D & Bjorner J (2019) . Value in Health, Vol. 22 (pp S685-S686)
  • Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernández M (2019) . Value in Health, Vol. 22(Suppl. 3) (pp S891-S891). Copenhagen, Denmark, 2 November 2019 - 6 November 2019.
  • Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernandez M (2019) MAPPING FROM VISUAL ACUITY TO UTILITY IN PATIENTS WITH MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION USING DATA FROM THE LEAVO TRIAL. VALUE IN HEALTH, Vol. 22 (pp S891-S891)
  • Acaster S, Mukuria C, Rowen D, Brazier J, Wainwright C, Quon B, Duckers J, Quittner AL, Lou Y, Sosnay P & McGarry L (2019) DEVELOPMENT OF THE CYSTIC FIBROSIS QUESTIONNAIRE-REVISED PREFERENCE BASED SCORING ALGORITHM. PEDIATRIC PULMONOLOGY, Vol. 54 (pp S443-S443)
  • Pickard AS, Monteiro A, Kuharic M, Mukuria C, Peasgood T & Brazier J (2019) Extending the QALY project in the United States: face and content validity of items for a new preference-based measure. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S165-S165)
  • Keetharuth A, Bjorner JB, Rowen D & Brazier J (2019) Using item response theory to construct a health classification system and select health states for valuation for the Preference-Based Index from the Recovering Quality of Life (ReQoL) outcome measure. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S68-S68)
  • Blome C, Carlton J, Heesen C, Janssen MF, Lloyd A, Otten M, Sommer R & Brazier J (2019) How to capture fluctuating health impairments in people with multiple sclerosis: development of an intensive longitudinal assessment of the EQ-5D-5L. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S164-S164)
  • Norman R, Mercieca-Bebber R, Rowen D, Brazier J, Cella D, Pickard AS, Street DJ, Viney R, Revicki D & King M (2019) UK utility weights for the cancer-specific EORTC QLU-C10D: Why, how and when to use?. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S11-S12)
  • Connell J, Carlton J, Peasgood T, Mukuria C, Brazier J, Augustovski F, Belizan M, Engel L, Greiner W, Hanna L , Ludwig K et al (2018) Extending the QALY: developing and testing the proposed items for a new generic measure - results from qualitative review and face validity with patients, social care users and carers. QUALITY OF LIFE RESEARCH, Vol. 27 (pp S189-S189)
  • Keetharuth A, Barkham M & Brazier J (2018) Interpreting changes in scores: the case of the Recovering Quality of Life (ReQoL). QUALITY OF LIFE RESEARCH, Vol. 27 (pp S161-S161)
  • Mukuria C, Connell J, Carlton J, Peasgood T, Brazier J, Scope A, Clowes M & Jones K (2018) . Value in Health, Vol. 21 (pp S110-S110)
  • Connell J, Carlton J, Grundy A, Taylor Buck E, Keetharuth AD, Ricketts T, Barkham M, Robotham D, Rose D & Brazier J (2018) . Quality of Life Research, Vol. 27(7) (pp 1893-1902)
  • Petersen KD, Chen G, Mpundu-Kaambwa C, Stevens K, Brazier J & Ratcliffe J (2018) . The Patient - Patient-Centered Outcomes Research, Vol. 11(1) (pp 29-37)
  • King MT, Norman R, Mercieca-Bebber R, Rowen D, Bonnet P, Cella D, Pickard AS, Brazier JE, Viney R & Revicki DA (2017) Development of United Kingdom value set for EORTC QLU-C10D: multi-attribute utility classification for the EORTC-QLQ-C30. QUALITY OF LIFE RESEARCH, Vol. 26(1) (pp 50-50)
  • Velikova G, Valderas JM, Potter C, Batchelder L, A’Court C, Baker M, Bostock J, Coulter A, Fitzpatrick R, Forder J , Fox D et al (2017) . Health and Quality of Life Outcomes, Vol. 15(S1)
  • Elliott J, Carlton J, Rowen D & Brazier J (2017) Changing HbA(1c) units: a hindarance, not a help to patients. DIABETOLOGIA, Vol. 60 (pp S342-S342)
  • Lescrauwaet B, Brazier J, Aly A, Hirneiß C & Patel P (2016) . Value in Health, Vol. 19(7) (pp A571-A571)
  • Willson J, Mukuria CW, Labeit A, Gunsoy N, Starkie Camejo H, Alfonso-Cristancho R & Brazier J (2016) . Value in Health, Vol. 19(7) (pp A385-A385)
  • Ballinger RS, Macey J, Lloyd AJ & Brazier JE (2016) . Value in Health, Vol. 19(7) (pp A513-A513)
  • Bjorner JB, Rendas-Baum R, Carson RT, Boer R, Tucker C, Andrae DA & Brazier JE (2016) . Value in Health, Vol. 19(7) (pp A379-A379)
  • King MT, Norman R, Viney R, Costa D, Brazier J, Cella D, Gamper E, Kemmler G, McTaggart-Cowan H, Peacock S , Pickard AS et al (2016) . Value in Health, Vol. 19(7) (pp A807-A807)
  • Brazier J, Mukuria CW, Peasgood T & Bjorner JB (2016) . Value in Health, Vol. 19(7) (pp A389-A389)
  • Croudace T, Brazier J, Gutacker N, Street A, Robotham D, Waterman S, Rose D, Satkunanathan S, Wykes T, Nasr N , Enderby P et al (2016) . Health and Quality of Life Outcomes, Vol. 14(Suppl 1), 9 June 2016 - 9 June 2016.
  • Carlton J, Rowen D, Elliott J, Brazier J, Stevens K, Basarir H & Labeit A (2016) Developing a PROM to evaluate self-management in diabetes (HASMID): giving patients a voice. HEALTH AND QUALITY OF LIFE OUTCOMES, Vol. 14
  • Brazier J (2016) Well-being: what is it, how does it compare to health and what are the implications of using it to inform health policy. HEALTH AND QUALITY OF LIFE OUTCOMES, Vol. 14
  • Rowen D, Labeit A, Brazier JE, Stevens K, Elliott J, Mulhern B, Carlton J, Basarir H & Meadows K (2016) Valuing the impact of self-management on quality of life in diabetes using discrete choice experiments. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 134-134)
  • Bjorner JB, Croudace T, Keetharuth A, Brazier JE & Browne J (2016) Factor analyses identified one dominant global factor in a new scale for recovering quality of life (ReQoL) for mental health patients. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 95-95)
  • Brazier JE, Keetharuth A, Connell J, Carlton J, Buck ET, Ricketts T & Barkham M (2016) First validation of the short recovering quality of life (ReQoL) measure. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 96-96)
  • Keetharuth A, Brazier JE, Connell J, Carlton J, Ricketts T, Buck ET, Barkham M, Bjorner JB, Croudace T & Browne J (2016) Constructing the short recovering quality of life (ReQoL) measure for use in a mental health population: combining psychometric and qualitative evidence. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 70-70)
  • Connell J, Brazier JE, Carlton J, Buck ET, Grundy A, Keetharuth A, Ricketts T & Barkham M (2016) Developing the recovery of quality of life measure (ReQoL): the views of mental health service users on potential items. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 46-47)
  • Patel PJ, Brazier J, Hirneiss C, Tangelder M & Lescrauwaet B (2016) Prevalence of Metamorphopsia in Patients with Vitreomacular Traction and its Impact on Quality of Life: The MeMo Study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 57(12)
  • Brazier J, Keetharuth A, Connell J, Barkham M, Carlton J, Ricketts T & Taylor-Buck L (2016) . Value in Health, Vol. 19(3) (pp A190-A190)
  • Paul C, Barker J, Klekotka P, Milmont C, Viswanathan H, Nirula A, Brazier J, Harrison D, Mutebi A & Kricorian G (2016) Improvements in health-related quality of life measured by SF-36 and EQ-5D in patients with moderate to severe plaque psoriasis treated with brodalumab. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, Vol. 74(5) (pp AB256-AB256)
  • Brazier J, Hirneiß C, Tangelder M, Lescrauwaet B & Patel P (2016) . Value in Health, Vol. 19(3) (pp A126-A126)
  • Mulhern B, Norman R, Viney R, Lorgelly P, Lancsar E, Ratcliffe J & Brazier J (2016) . Value in Health, Vol. 19(3) (pp A94-A94)
  • Finch AP, Brazier J & Mukuria CW (2015) . Value in Health, Vol. 18(7) (pp A744-A744)
  • Mukuria C, Brazier J & Peasgood T (2015) Does EQ-5D-5L account for the impact of limitations in activities of daily livings (ADLS) on social care outcomes, capabilities and well-being?. QUALITY OF LIFE RESEARCH, Vol. 24 (pp 179-179)
  • Boegelund M, Feher M, Nikolajsen A, Vega-hernandez G & Brazier JE (2015) The Willingness to Pay for Improvements in Insulin Injectable Therapies for People with Type 2 Diabetes in North America. DIABETES, Vol. 64 (pp A349-A349)
  • Feher M, Nikolajsen A, Vega-Hernandez G, Boegelund M & Brazier JE (2015) The Willingness to Pay for Improvements in Insulin Injectable Therapies for People with Type 2 Diabetes in the UK, France, and the Netherlands. DIABETES, Vol. 64 (pp A349-A349)
  • Mukuria CW, Brazier J & Rafia R (2015) . Value in Health, Vol. 18(3) (pp A210-A211)
  • Costa D, King M, Aaronson N, Brazier J, Cella D, Grimison P, Janda M, McTaggart-Cowan H, Pickard S, Rowen D & Di Sipio T (2014) DO CANCER PATIENTS DISTINGUISH BETWEEN THE IMPORTANCE AND SEVERITY OF THEIR QUALITY OF LIFE CONCERNS?. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 10 (pp 31-31)
  • Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella D, Fayers PM, Grimison P, Janda M, McTaggart-Cowan H, Norman R , Pallant J et al (2014) THE DEVELOPMENT OF CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENTS FROM THE EORTC QLQ-C30 AND FACT-G. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 10 (pp 31-31)
  • Mukuria C & Brazier JE (2014) Health-related quality of life and well-being. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 62-62)
  • Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella D, Grimison P, Janda M, McTaggart-Cowan H, Pickard AS, Arbuckle R , Rowen D et al (2014) Do cancer patients distinguish between the importance and severity of their quality of life concerns?. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 122-122)
  • Rowen D, Brazier JE, Keetharuth A, Tsuchiya A, Robinson A & Mukuria C (2014) Comparison of an online survey and face-to-face interviews for eliciting societal preferences. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 49-49)
  • Keetharuth A, Brazier J, Gibbons E, Ricketts T, Khan M, Connell J & Barkham M (2014) PROMs in Secondary Mental Health Services in the UK: a Feasibility Study and Lessons Learnt. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, Vol. 17 (pp S10-S10)
  • Brazier JE, Connell J & O’Cathain A (2014) . Value in Health, Vol. 17(3) (pp A194-A194)
  • Tolley K, Miners A, Brazier J, Pericleous LM, Sharma T, Petersen J & Lonergan T (2013) . VALUE IN HEALTH, Vol. 16(7) (pp A386-A387)
  • Wu M & Brazier J (2013) . Value Health, Vol. 16(3) (pp A26). United States
  • Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, Ratcliffe J & Street DJ (2012) . VALUE IN HEALTH, Vol. 15(7) (pp A605-A606)
  • King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella D, Fayers PM, Pallant JF, Peacock S, Pickard S, Rowen D , Velikova G et al (2012) THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 8 (pp 335-335)
  • Jr LL, Yang Y, Brazier JE, Rowen D, Tsuchiya A & Young TA (2012) Valuing a vision 'bolt-on' item for the EQ-5D. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 53-54)
  • Young TA, Rowen D, Mukuria C, Brazier JE & Jr LL (2012) Appropriate mapping functions in HRQL: a series of models mapping from FACT-G to EQ-5D. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 11-11)
  • Mulhern B, Tsuchiya A, Brazier JE & Rowen D (2012) How do respondents perceive health state valuation tasks? A 'think aloud' study investigating time trade off and discrete choice experiments. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 53-53)
  • Palfreyman S & Brazier J (2012) THE DEVELOPMENT AND VALUATION OF THE SHEFFIELD PREFERENCE BASED LEG ULCER QUESTIONNAIRE (SPVU-5D). VALUE IN HEALTH, Vol. 15(4) (pp A126-A126)
  • King M, Costa DSJ, Aaronson NK, Brazier J, Cella DF, Fayers P, Pallant JF, Peacock S, Pickard AS, Rowen D , Velikova G et al (2012) . VALUE IN HEALTH, Vol. 15(4) (pp A225-A225)
  • Young TA, Brazier JE, Rowen D, Tsuchiya A & Yang Y (2012) The impact of adding a generic dimension to a condition-specific preference-based measure. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 10-10)
  • Wong CKH, Lam CLK, Ma KP, McGhee SM, Law WL, Poon JTC, Chan P, Kwong DLW, Tsang J, Rowen DL & Brazier JE (2012) Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to Preference-based Values Measured by SF-6D in Patients with Colorectal Neoplasm. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 26-26)
  • Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Pallant JS, Peacock S, Pickard S, Rowen D , Velikova G et al (2012) Adaptation of a method for developing a preference-based measure from a descriptive health-related quality of life measure (HRQOL): a confirmatory versus exploratory approach for the cancer-specific QLQ-C30. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 31-31)
  • Rowen D, Brazier JE, Tsuchiya A, Young T & Ibbotson R (2012) The impact of condition labelling on health state utility values. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 11-11)
  • Ara R & Brazier J (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A428-A428)
  • Peasgood T, Ward SE & Brazier J (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A462-A462)
  • Ara R & Brazier J (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A427-A427)
  • Papaioannou D, Peasgood T, Brazier J & Parry G (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A239-A239)
  • Meadows K, Mulhern B, Rowen D & Brazier J (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A242-A242)
  • Brazier J, Rowen D, Tsuchiya A, Young T & Ibbotson R (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A457-A457)
  • Ara R & Brazier J (2010) ESTIMATING HEALTH STATE UTILITY VALUES FOR COMORBID HEALTH CONDITIONS. VALUE HEALTH, Vol. 13(7) (pp A334-A335)
  • Cruz LN, Camey SA, Hoffmann JF, Brazier J, Rowen D, Fleck MP & Polanczyk CA (2010) ESTIMATING THE SF-6D VALUE SET FOR A POPULATION BASED SAMPLE OF BRAZILIANS. VALUE HEALTH, Vol. 13(7) (pp A240-A240)
  • Smith SC, Mulhern B, Brazier JE, Lamping DL, Knapp M, Rowen D, Loftus V & Banerjee S (2010) What do people with dementia and their proxies say about HRQL? A quantitative test of qualitative findings. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 14-14)
  • Rowen D, Mulhern B, Brazier J, Jacoby A, Marson T, Latimer N, Snape D, Baker G & Hughes D (2010) Using the Liverpool Quality of Life battery to develop a health state classification system for Epilepsy. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 57-57)
  • Mulhern BJ, Smith S, Brazier J, Rowen D, Lamping D, Knapp M, Loftus V & Banerjee S (2010) Developing a health state classification system for dementia using Rasch analysis. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 35-36)
  • Mutebi A, Brazier J & Walters S (2010) A COMPARISON OF THE DISCRIMINTATIVE AND EVALUATIVE PROPERTIES OF THE SF-36 AND THE SF-6D INDEX. VALUE HEALTH, Vol. 13(3) (pp A17-A17)
  • Szende A, Brazier J, Schaefer C, Deuson R, Isitt J & Vyas P (2009) MEASUREMENT OF HEALTH UTILITY VALUES IN THE UK FOR HEALTH STATES RELATED TO IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA (ITP). VALUE HEALTH, Vol. 12(7) (pp A383-A383)
  • Schwenkglenks M, Szucs TD, Brazier JE, Blackman DJ, Cyr P, Olchanski N & Stone GW (2009) COST-EFFECTIVENESS OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIIA INHIBITOR IN THE TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION-A HORIZONS TRIAL ANALYSIS USING UK VALUATIONS. VALUE HEALTH, Vol. 12(7) (pp A334-A335)
  • McTaggart-Cowan HM, Tsuchiya A, O'Cathain A & Brazier JE (2009) THE IMPACT OF DISEASE ADAPTATION ON GENERAL POPULATION VALUES. VALUE HEALTH, Vol. 12(3) (pp A35-A35)
  • Yang Y, Brazier J, Tsuchiya A & Coyne K (2009) . Value in Health, Vol. 12(1) (pp 159-166)
  • Tilling CJ, Krol M, Tsuchiya A, Brazier JE & Brouwer W (2008) IN OR OUT? EMPIRICAL EVIDENCE ON INCOME LOSSES IN HEALTH STATE VALUATIONS AND IMPLICATIONS FOR ECONOMIC EVALUATIONS. VALUE HEALTH, Vol. 11(6) (pp A563-A564)
  • Ara R & Brazier JE (2008) Predicting a mean EQ-5D preference-based score from the 8 mean SF-36 dimension scores when individual data is not available. VALUE HEALTH, Vol. 11(3) (pp A178-A179)
  • Ara R & Brazier JE (2008) Predicting SF-6D preference-based utilities using mean SF-36 health dimension scores when patient level data are not available. VALUE HEALTH, Vol. 11(3) (pp A178-A178)
  • Cosstick R, Buckingham J, Brazier J & Fisher J (2007) . Nucleosides Nucleotides Nucleic Acids, Vol. 26(6-7) (pp 555-558). United States
  • Gaynor JW, Brazier J & Cosstick R (2007) . Nucleosides Nucleotides Nucleic Acids, Vol. 26(6-7) (pp 709-712). United States
  • Burness CE, Howlett S, Brazier J, Grunewald RA & Reuber M (2007) Outcome of tailored psychotherapy for nonepileptic seizures and other functional neurological symptoms. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 78(9) (pp 1016-1016)
  • Bansback N, Harrison M, Brazier J, Davies L, Kopec J, Marra C, Symmons D & Anis A (2007) Health state utility values in rheumatic diseases - A review. ANNALS OF THE RHEUMATIC DISEASES, Vol. 66 (pp 256-256)
  • Holmes M, Brazier J, Tumur I, Ferriter M, Parry G, Dent-Brown K & Paisley S (2007) A probabilistic cost-effectiveness analysis of psychological therapies including dialectical behaviour therapy for borderline personality disorder.. J MENT HEALTH POLICY, Vol. 10 (pp S18-S19)
  • Brazier J, Tumur I, Holmes M, Ferriter M, Dent-Brown K, Paisley S & Parry G (2007) Psychological therapies for borderline personality disorder: A systematic review. J MENT HEALTH POLICY, Vol. 10 (pp S5-S6)
  • Ara RM & Brazier J (2006) Mapping generic quality of life measurements to disease specific variables in patients with Ankylosing Spondylitis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 273-273)
  • Brazier JE, Yang Y, Tsuchiya A & Coyne K (2006) . Value in Health, Vol. 9(3) (pp A98-A98)
  • Reeves P & Brazier JE (2006) Estimating a preference-based index from a condition specific measure - The King's Health Questionnaire. VALUE HEALTH, Vol. 9(3) (pp A97-A98)
  • Brazier JE & Ratcliffe J (2005) ESTIMATING HEALTH STATE VALUATION MODELS FROM ORDINAL HEALTH STATE PREFERENCE DATA (RANK AND DISCRETE CHOICE EXPERIMENTS) AND COMPARING TO TTO VALUATIONS. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2110-2110)
  • Yang Y, Tsuchiya A, Brazier JE & Young TA (2005) ESTIMATING A PREFERENCE-BASED SINGLE INDEX FROM THE ASTHMA QUALITY OF LIFE QUESTIONNAIRE. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2012-2012)
  • Young TA, Yang Y, Brazier JE & Tsuchiya A (2005) USING RASCH ANALYSIS TO AID THE CONSTRUCTION OF PREFERENCE BASED MEASURES FROM EXISTING QUALITY OF LIFE INSTRUMENTS. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2081-2081)
  • Marra CA, Coombes ME, Moadebi S, Yeh E, FitzGerald JM, Elwood K, Brazier JE & Marra F (2005) COMPARISON OF THE HUI-3 AND SF-6D IN PATIENTS WITH LATENT AND ACTIVE TUBERCULOSIS. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2020-2020)
  • Gray DT, Walters S, Spertus J, Brazier J & Horvath K (2005) Quality-adjusted survival and cost-effectiveness of transmyocardial revascularization using the CO2 laser. CIRCULATION, Vol. 111(20) (pp E319-E319)
  • Palfreyman SJ, Michaels JA, Campbell WB, Brazier JE, MacIntyre JB, Ratcliffe J & Rigby K (2005) A prospective clinical trial of the management and outcome of uncomplicated varicose veins. BRITISH JOURNAL OF SURGERY, Vol. 92(4) (pp 506-506)
  • Michaels JA, Campbell WB, Brazier JE, MacIntyre JB, Palfreyman SJ, Ratcliffe J & Rigby K (2005) Randomized trial of treatment for uncomplicated varicose veins: surgery is clinically and cost effective. BRITISH JOURNAL OF SURGERY, Vol. 92(4) (pp 506-507)
  • Ratcliffe J, Brazier J, Palfreyman S & Michaels J (2004) An exploration of the discrepancies between health state valuations of patients and the general population. VALUE HEALTH, Vol. 7(6) (pp 775-775)
  • Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE, Chalmers A & Anis AH (2004) A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. MEDICAL CARE, Vol. 42(11) (pp 1125-1131)
  • Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2004) The cost-effectiveness of bisphosphonates, raloxifene and teriparatide in women with a prior fracture, low BMD and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S39-S39)
  • Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2004) The cost-effectiveness of calcium and vitamin D in women with low dietary calcium intake. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S39-S40)
  • Brazier JE, Ratcliffe J, Michaels J & Palfreyman S (2004) COMPARISON OF PATIENT AND GENERAL POPULATION VALUES: THE CASE OF VARICOSE VEINS. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1557-1557)
  • Murray CJC, Brazier J, Espallargues M & Bansback N (2004) A COMPARISON OF PREFERENCE-BASED MEASURES IN PATIENTS WITH AGE RELATED MACULAR DEGENERATION. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1509-1509)
  • Brazier JE (2004) PATIENT INVOLVEMENT IN VALUING HEALTH STATES FOR USE IN ECONOMIC EVALUATION. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1571-1571)
  • Lam CL, Brazier J & McGhee SM (2004) PILOT TEST OF SF-6D VALUATION SURVEY ON CHINESE ADULTS IN HONG KONG. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1509-1509)
  • Stevenson MD, Brazier JE, Lloyd-Jones M, Calvert N, Oakley J & Kanis JA (2004) The cost-effectiveness of bisphosphonates, raloxifene and hormone replacement therapy in women with established osteoporosis and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S111-S111)
  • Stevenson MD, Lloyd-Jones M, Brazier JE, Calvert N, Oakley J & Kanis JA (2004) The cost-effectiveness of calcium and vitamin D supplementation in women with low dietary intake of these nutrients and at risk of osteoporosis. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S87-S88)
  • Brazier JE, Zoellner YF, Platts M & Towers I (2003) Developing a preference-based measure for postmenopausal health. VALUE HEALTH, Vol. 6(6) (pp 606-606)
  • McCloskey E, Jalava T, Oden A, Johansson H, Kayan K, Beneton M, Brazier J, Nicholl J, Richards A, Cliffe J , Reaney L et al (2003) The efficacy of clodronate (Bonefos (R)) to reduce the incidence of osteoporotic fractures in elderly women is independent of the underlying BMD.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S92-S92)
  • Smith S, Brazier JE, Parry G & Edbrooke DL (2003) SF-36 and EQ-5D in adult ICU patients. INTENSIVE CARE MEDICINE, Vol. 29 (pp S176-S176)
  • Fry AM, Round A, Stein K, Brazier J & Milne R (2003) Justifying the development of a lay panel to produce utilities for use in health technology assessments (HTAS): Review of current issues,and views of technology appraisal committee members. VALUE HEALTH, Vol. 6(3) (pp 305-305)
  • Marra CA, Woolcott J, Offer R, Guh D, Brazier JE, Esdaile JM & Anis AH (2002) A within subject comparison of four indirect utility measures in rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S74-S74)
  • Marra CA, Woolcott J, Shojania K, Brazier JE, Esdaile JM & Anis AH (2002) Comparison of health state utilities using community and patient preference weights derived from a survey of patients with rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S74-S74)
  • Stevenson MD, Brazier JE, Kanis J & Lloyd-Jones M (2000) Cost-effectiveness of current treatments for established female osteoporosis. OSTEOPOROSIS INT, Vol. 11 (pp S11-S11)
  • deTakats D, McCloskey E, Bernard J, Orgee J, Coombes G, Khan S, Nicholl J, Brazier J, Beneton M, Charlesworth D & Kanis J (1997) Effects of clodronate on hip BMD in community-dwelling women: Randomised trial: 1 year results.. J BONE MINER RES, Vol. 12 (pp S490-S490)
  • MCCLOSKEY E, KHAN S, ORGEE J, COOMBES G, TAUBE T, PHILLIPS R, BRAZIER J, NICHOLL J & KANIS J (1995) ORAL CLODRONATE PREVENTS BONE LOSS AT THE HIP IN ELDERLY WOMEN - A PILOT-STUDY. J BONE MINER RES, Vol. 10 (pp S356-S356)
  • AARONSON NK, ACQUADRO C, ALONSO J, APOLONE G, BECH P, BRAZIER J, BULLINGER M, FUKUHARA S, GANDEK B, KAASA S , KELLER S et al (1994) TRANSLATING HEALTH - THE INTERNATIONAL QUALITY-OF-LIFE ASSESSMENT (IQOLA) PROJECT. QUAL LIFE RES, Vol. 3(1) (pp 66-66)
  • WARE JE, KELLER S, BENTLER PM, SULLIVAN M, BRAZIER J & GANDEK B (1994) COMPARISON OF HEALTH-STATUS MEASUREMENT MODELS AND THE VALIDITY OF SF-36 IN GREAT-BRITAIN, SWEDEN AND THE USA. QUAL LIFE RES, Vol. 3(1) (pp 68-68)
  • Czoski-Murray C, Carlton C, Young T, Brazier J, Papo N & Kwon Kang H () Health state valuation for ARMD visual impairment states using simulation lenses. 6th iHEA World Congress on Health Economics. Copenhagen, Denmark, July 2007.
  • Brazier J, Tsuchiya A & Yang Y () A Condition-Specific Preference-Based Instrument: The Asthma Quality of Life Utility Index (AQL-5D)

Reports

  • Keetharuth D, Rowen D, Bjorner JB & Brazier J (2020) Estimating a Preference-Based Index for mental health from the Recovering Quality of Life (ReQoL) measure: Valuation of ReQoL-UI
  • Rowen D, Brazier J, Wong R & Wailoo A (2020) Measuring and valuing health-related quality of life when sufficient EQ-5D data is not available
  • Rowen D, Keetharuth D, Poku E, Wailoo A, Wong R, Pennington R & Brazier J (2019) A review of the psychometric performance of paediatric preference-based measures used to generate utility values for children
  • Mukuria C, Rowen D, Peasgood T & Brazier JE (2016) An empirical comparison of well-being measures used in the UK
  • Karimi M, Brazier J & Basarir H (2016)
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia.
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular.
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer.
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE
  • Ara , Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer.
  • Keetharuth D, Mulhern B, Wong R, Ara R, Franklin M, Jones G & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audit Work Package 2. How should PROMS data be collected?
  • Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme.
  • peasgood T, Brazier JE, mukuria C & Rowen D (2014) A conceptual comparison of well-being measures used in the UK.
  • Kearns B, Rafia R, Leaviss J, Preston L, Wong R, Brazier J, Palmer S & Ara R (2014) Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Part 1, Executive summary, introduction, clinical reviews and conceptual modelling.
  • Kearns B, Rafia R, Leaviss J, Preston L, Wong R, Brazier J, Palmer S & Ara R (2014) Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Part 2. Independent economic evaluation: methods and results, discussion and conclusion
  • Kearns B, Rafia R, Leaviss J, Preston L, Wong R, Brazier J, Palmer S & Ara R (2014) Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Appendices.
  • Rowen D, Brazier J, Mukuria C, Keetharuth A, Rise Hole A, Tsuchiya A, Whyte S & Shackley P (2014) Update: Eliciting societal preferences for weighting QALY's according to burden of illness, size of gain and end of life
  • Ara R, Kearns B, Mukuria C, van Hout B & Brazier JE (2013) Examining productivity losses associated with health related quality of life using patient and general population data.
  • Whyte S, Brazier J, Rowen D, Mukuria C, Keetharuth A, RiseHole A, Tsuchiya A & Shackley P (2013) Eliciting societal preferences for burden of illness, therapeutic improvement and end of life for value based pricing: a report of the main survey
  • ara R, van hout B, Kearns B & Brazier JE (2013) Case-mix methodology for the NHS outcomes framework GP Patient Survey Questionnaire Data
  • Ara R, Keetharuth D, Papaioannou D, Cantrell A & Brazier JE (2011) Evaluating public health interventions for obesity from the perspective of local health authorities.
  • Parry G, Barkham M, Brazier J, Dent-Brown K, Hardy G, Kendrick T, Rick J, Chambers E, Chan T, Connell J , Hutten R et al (2011) An evaluation of a new service model: Improving Access to Psychological Therapies demonstration sites 2006-2009. Final report. NIHR Service Delivery and Organisation programme
  • Hutten R, Parry GD, Barkham , Brazier , Dent-Brown , Hardy , Rick J, Chambers , Connell , de Lusignan S , Mukuria et al (2011) An evaluation of a new service model: Improving Access to Psychological Therapies demonstration sites 2006-2009, Final Report.
  • Brazier J & Rowen D (2011) NICE DSU Technical Support Document 11: Alternatives to EQ-5D for generating health state utility values

Scholarly editions

  • Mulhern B, Rowen D, Brazier J, Jacoby A, Marson T, Snape D, Hughes D, Latimer N & Baker GA (2010) Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report.
  • Brazier J, Rowen D, Yang Y & Tsuchiya A (2009) Using rank and discrete choice data to estimate health state utility values on the QALY scale.
  • McTaggart-Cowan H, O'Cathain A, Tsuchiya A & Brazier J (2009) A qualitative study exploring the general population’s perception of rheumatoid arthritis after being informed about disease adaptation.
  • Rowen D, Brazier J, Tsuchiya A, Hernández M & Ibbotson R (2009) The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results.
  • McTaggart-Cowan H, Brazier J & Tsuchiya A (2008) Combining Rasch and cluster analysis: a novel method for developing rheumatoid arthritis states for use in valuation studies.
  • Peasgood T, Brazier J & Ward S .
  • Tappenden P, Brazier J & Ratcliffe J Does the National Institute for Health and Clinical Excellence take account of factors such as uncertainty and equity as well as incremental cost-effectiveness in commissioning health care services? A binary choice experiment.

Posters

  • Schneider P, van Hout B, Heisen M, Brazier JE & Devlin N (2022) P60 A New Online Tool for Valuing Health States: Eliciting Personal Utility Functions for the EQ-5D-5L.
  • Mukuria C, Peasgood T, Brazier J, Rowen D & Norman R (2020) E-QALY: valuing the items for a new generic preference-based measure using time trade-off and discrete choice experiments.
  • Rees A, Paisley S, Brazier J, Cantrell A, Poku E & Williams K (2013) DEVELOPMENT OF THE SCHARR HUD (HEALTH UTILITIES DATABASE).
  • Keetharuth A, Rowen D, Bjorner J & Brazier J Estimating a Preference-Based Index from the Recovering Quality of Life measure for economic evaluation in the area of mental health: Valuation of ReQoL-UI.
  • Brazier J, Keetharuth A, Connell J, Carlton J, Buck ET, Ricketts T & Barkham M Constructing a classification system for a new QALY measure in mental health: recovering quality of life (ReQoL).
  • Brazier J, Keetharuth A, Connell J, Barkham M & Ricketts T ReQoL: Recovering Quality of LIfe.
  • Connell J, Brazier J & Keetharuth A Development of the Recovering Quality of Life Measure (2014).
  • Brazier J, Keetharuth A, Connell J, Carlton J, Ricketts T, Buck ET & Barkham M First validation of the Recovering Quality of Life measures: a new PROM for use in mental health.
  • Mukuria C, Brazier J & Rafia R Does the generic cancer outcome measure EORTC QLQ-C30 work in Myelofibrosis? (ISPOR 20th Annual International Meeting 16-20 May 2015).
  • Palfreyman S & Brazier J Development of a preference-based, condition specific patient reported outcome measure for use with venous ulceration (2012).
  • Wu M, Brazier J, Blackburn J, Cooper CL, Relton C & Smith C Examining the incremental impact of long-standing health conditions on subjective well-being – is there anything missing from the EQ-5D? (ISPOR 18th Annual International Meeting 18-22 May 2013).
  • Ara R & Brazier J Are general population data suitable for approximating baseline utility values in economic models?.
  • Finch AP, Brazier J & Mukuria C Selection of bolt-ons after factor analysis identification: are linear regression models a useful technique?.
  • Keetharuth D, Connell J, Karimi M, Barkham M, Ricketts T & Brazier J ReQol - Recovering Quality of Life (Quality in Mental Health Conference 23 March 2015).
  • Brazier J, Rowen D, Tsuchiya A, Young T & Ibbotson R The impact of conditions labels on health state values.
  • Ara R & Brazier J Estimating SF-6D health state utility values for comorbid health conditions.
  • Brazier J & Sculpher M Policy Research Unit in Economic Evaluation of Health and Care Interventions.

Datasets

  • Pennington R, Hernandez M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J .
  • Powell P, Carlton J, Rowen D & Brazier J .
  • Powell P, Carlton J, Rowen D & Brazier J .

Presentations

  • Ratcliffe J, Chen G, Huynh E, Xu F, Stevens K, Brazier J & Swait J .

Other

  • Brazier J, Peasgood T, Mukuria C, Luo N, Mulhern B, Pickard AS, Augustovski F, Greiner W & Engel L (2022) . Value in Health.
  • Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS , Rowen D et al (2017) . Quality of Life Research, 26(8), 2247-2248.
  • Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS , Rowen D et al (2016) . Quality of Life Research, 25(9), 2401-2401.
  • King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R , Pickard AS et al (2016) . Quality of Life Research, 25(10), 2683-2683.
  • Lu G, Brazier JE & Ades AE (2013) . Value in Health, 16(1), 217-218.
  • Brazier J (2010) . BRIT J PSYCHIAT, 197(5), 348-349.
  • Rowen D, Carlton J, Brazier JE, Mulhern B, Palfreyman S, Stevens K & Tsuchiya A (2010) . BMJ (Online), 341(7776), 746.
  • Stevens K, McCabe C & Brazier J (2007) . HEALTH ECON, 16(7), 759-761.
  • Brazier J & McCabe C (2007) . Health Econ, 16(6), 645-647.
  • Parsons HK, Tomlin K, Metcalf SC, Brazier JE & Dockrell DH (2006) . QJM, 99(5), 348-349.
  • Stevens KJ, McCabe CJ & Brazier JE (2006) . Health Econ, 15(5), 527-533.
  • Harper R, Brazier J & Waterhouse J (1998) Comparison of outcome measures in patients with COPD - Reply. THORAX, 53(9), 813-813.
  • BRAZIER J (1995) HEALTH-STATUS MEASUREMENT - A PERSPECTIVE ON CHANGE - BROOKS,RG. HEALTH ECON, 4(2), 149-150.
  • LOWY A, FALL M & BRAZIER J (1993) SKIN BIOPSIES BY GPS. BRIT J GEN PRACT, 43(376), 478-478.
  • NICHOLL JP & BRAZIER JE (1993) . LANCET, 341(8836), 47-47.
  • Nicholl J, Brazier JE & Williams BT (1993) Management of trauma [20]. British Medical Journal, 307(6905), 683-684.
  • BRAZIER J, HARPER R, JONES N, THOMAS K, WESTLAKE L & USHERWOOD T (1992) VALIDATING THE SF-36 - REPLY. BRIT MED J, 305(6854), 646-646.
  • BRAZIER JE & LOWY A (1991) PERFORMANCE OF SKIN BIOPSIES BY GENERAL-PRACTITIONERS. BRIT MED J, 303(6815), 1472-1472.
  • GEORGE SL & BRAZIER JE (1990) CASELOAD OR WORKLOAD. BRIT MED J, 301(6751), 556-556.
  • PITT FA & BRAZIER J (1990) HORMONE REPLACEMENT THERAPY FOR OSTEOPOROSIS. LANCET, 335(8695), 978-978.
  • PAGE H & BRAZIER J (1989) BENEFITS OF INVITRO FERTILIZATION. LANCET, 2(8675), 1327-1328.
  • Alshreef A, Brazier J, Poku E, Hykin P & Sivaprasad S () .

Preprints

  • Durno N, Zormpas E, Schmid R, Heisen M, Hartl K, Ethgen O, Szilvasy Z, Friedel E, Wong O, Charman T , Cáceres ASJ et al () , Research Square Platform LLC.
  • Hartl K, Durno N, Schmid R, Heisen M, Ethgen O, Szilvasy Z, Friedel E, Wong O, Charman T, Cáceres ASJ , Mühlbacher A et al () , Research Square Platform LLC.
  • Acaster S, Mukuria C, Rowen D, Brazier JE, Wainwright CE, Quon BS, Duckers J, Quittner AL, Lou Y, Sosnay P & McGarry LJ () , Research Square Platform LLC.
  • Tilling CJ, Krol M, Attema AE, Tsuchiya A, Brazier J, van Exel J & Brouwer W () .
  • Brazier J, Yang Y & Tsuchiya A () .
  • Mukuria C, Peasgood T & Brazier J () Applying EuroQol Portable Valuation Technology to the EQ Health and Wellbeing Short (EQHWB-S): a pilot study.
Research group
Professional activities and memberships
  • NIHR Senior Investigator award 2009-2017
  • Membership of the .
  • Fellow of the Academy of Medical Sciences